Document:

Stockholders' Agreement

 Exhibit 4.2 
  
  
 ADDUS HOLDING CORPORATION 
 STOCKHOLDERS’ AGREEMENT 
 September 19, 2006 
  
  

 TABLE OF CONTENTS 
  

					
	ARTICLE I DEFINITIONS; RULES OF CONSTRUCTION	  	1
		
	ARTICLE II BOARD REPRESENTATION	  	9
			
	2.1.	  	Board Representation.	  	9
	2.2.	  	Voting Agreement.	  	11
	2.3.	  	Interim Director.	  	12
	2.4.	  	Committees; Subsidiaries.	  	12
	2.5.	  	Vacancies and Removal.	  	12
	2.6.	  	Non-Voting Observers.	  	13
	2.7.	  	Meetings; Expenses.	  	14
	2.8.	  	Board Expansion Option.	  	14
		
	ARTICLE III ISSUANCE AND TRANSFER OF SHARES	  	14
			
	3.1.	  	Future Stockholders.	  	14
	3.2.	  	Limitations on Transfers.	  	14
	3.3.	  	Repurchase Right.	  	16
	3.4.	  	Co-Sale Rights.	  	18
	3.5.	  	Preemptive Rights.	  	19
	3.6.	  	Right of First Refusal.	  	20
	3.7.	  	Approved Sale; Sale of the Corporation.	  	22
		
	ARTICLE IV PROTECTIVE PROVISIONS	  	23
			
	4.1.	  	Investor Director Protective Covenants.	  	23
	4.2.	  	Investor Stockholders Protective Covenants.	  	25
	4.3.	  	Management Stockholders Protective Covenants.	  	25
	4.4.	  	Subsidiaries and Committees.	  	26
		
	ARTICLE V ADDITIONAL AGREEMENTS	  	26
			
	5.1.	  	Information Rights.	  	26
	5.2.	  	Access to Records and Properties.	  	28
	5.3.	  	Regulatory Matters.	  	28
	5.4.	  	Expenses.	  	29
	5.5.	  	Irrevocable Proxy.	  	29
	5.6.	  	Director’s and Officer’s Insurance.	  	30
		
	ARTICLE VI MISCELLANEOUS	  	30
			
	6.1.	  	Termination.	  	30
	6.2.	  	Legend on Stock Certificates.	  	30
	6.3.	  	Governing Law; Dispute Resolution.	  	30
	6.4.	  	Severability.	  	32

  

 i 

					
	6.5.	  	Assignments; Successors and Assigns.	  	32
	6.6.	  	Amendments; Waivers.	  	32
	6.7.	  	Notices.	  	32
	6.8.	  	Headings.	  	33
	6.9.	  	Nouns and Pronouns.	  	33
	6.10.	  	Entire Agreement.	  	33
	6.11.	  	Counterparts.	  	33
	6.12.	  	Conflicting Agreements.	  	34
	6.13.	  	Third Party Reliance.	  	34
	6.14.	  	Consultation with Counsel, etc.	  	34
	6.15.	  	Prevailing Party.	  	34
	6.16.	  	Interpretation.	  	35
	6.17.	  	Lender.	  	35

  

 ii 

 FORM OF STOCKHOLDERS’ AGREEMENT 
 STOCKHOLDERS’ AGREEMENT (this “Agreement”) dated as of September 19, 2006, among Addus Holding Corporation, a Delaware
corporation (the “Corporation”), the Investors (as defined herein) and the Management Stockholders (as defined herein). 
 WHEREAS, each Stockholder (as defined herein) owns, as of the date hereof, that number of Shares (as defined herein) set forth opposite such Stockholder’s name on Annex I attached hereto or Annex II attached hereto, as
applicable; and 
 WHEREAS, the Stockholders believe it to be in the best interest of the Corporation and the Stockholders to provide
for the continued stability of the business and policies of the Corporation and its subsidiaries, as the same may exist from time to time. 
 NOW THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement, the sufficiency of which is hereby acknowledged, the parties agree as follows: 
 ARTICLE I 
 DEFINITIONS; RULES OF
CONSTRUCTION 
 The following terms have the following meanings: 
 “Additional Investor Directors” shall have the meaning set forth in Section 2.1(b)(v) hereof. 
 “Affiliate” means, with respect to any Person, any (a) director, officer, limited or general partner, member or stockholder holding
5% or more of the outstanding capital stock or other equity interests of such Person, (b) spouse, parent, sibling or descendant of such Person (or a spouse, parent, sibling or descendant of a Person specified in clause (a) above relating
to such Person) and (c) other Person that, directly or indirectly, through one or more intermediaries, controls, or is controlled by, or is under common control with, such Person. The term “control” includes, without limitation, the
possession, directly or indirectly, of the power to direct the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 
 “Agreement” shall have the meaning set forth in the preamble. 
 “Approved Sale” shall have the meaning set forth in Section 3.7 hereof. 
 “Arbitrator” shall have the meaning set forth in Section 6.3(b). 
 “Authorized Representatives” shall have the meaning set forth in Section 5.2 hereof. 
 “Board” means the Board of Directors of the Corporation. 

 “Board Expansion Option” shall have the meaning set forth in Section 2.8 hereof.

 “Business Day” means any day that is not a Saturday, Sunday or a day on which banking institutions in New York, New York
are not required to be open. 
 “Bylaws” shall mean the bylaws of the Corporation (as the same may be amended, modified or
supplemented from time-to-time after the date hereof). 
 “Cause” shall have the meaning set forth in the applicable
Employment Agreement, or, in the absence of an Employment Agreement, shall mean a Termination of Employment for Cause (as defined herein). 
 “Charter” means the Certificate of Incorporation of the Corporation in effect at the time in question, as the same may be amended, modified or supplemented from time-to-time after the date hereof (as permitted by the terms
of this Agreement). 
 “Common Stock” means the Corporation’s common stock, par value $0.001 per share. 
 “Common Stock Equivalent” means, at any time, one share of Common Stock or the right to acquire, whether or not such right is
immediately exercisable, one share of Common Stock, whether evidenced by an option, warrant, convertible security or other instrument or agreement. 
 “Corporation” shall have the meaning set forth in the preamble. 
 “Corporation Governing Body”
shall have the meaning set forth in Section 2.6(b) hereof. 
 “Co-Sale Notice” shall have the meaning set forth in
Section 3.4(a)(i) hereof. 
 “Co-Sale Transferee” shall have the meaning set forth in Section 3.4(a) hereof.

 “Co-Sale Transferor” shall have the meaning set forth in Section 3.4(a) hereof. 
 “Disability Notice” shall have the meaning set forth in Section 3.3(e) hereof. 
 “Employment Agreement” means, with respect to any Management Stockholder, the employment agreement entered into between such Management
Stockholder and Addus HealthCare, Inc. or Addus Management Corporation (as each such Employment Agreement may be amended, restated or otherwise supplemented from time-to-time). 
 “Eos Capital” means Eos Capital Partners III, L.P., a Delaware limited partnership. 
 “Eos Capital Director” shall have the meaning set forth in Section 2.1(b)(i). 
 “Eos Entities” means Eos Capital, Eos SBIC III and any Permitted Transferee thereof. 
  

 2 

 “Eos SBIC Directors” shall have the meaning set forth in Section 2.1(b)(ii).

 “Eos SBIC III” means Eos Partners SBIC III, L.P., a Delaware limited partnership. 
 “Equity Securities” means all shares of capital stock of the Corporation, all securities convertible into or exchangeable for shares of
capital stock of the Corporation, and all options, warrants, and other rights to purchase or otherwise acquire from the Corporation shares of such capital stock, including any stock appreciation or similar rights, contractual or otherwise.

 “Exchange Act” means the Securities and Exchange Act of 1934, as amended, or any successor federal statute, and the rules
and regulations promulgated thereunder. 
 “Excluded Stock” means (i) shares of Common Stock at any time issuable upon
the exercise of options granted to directors, officers, bona fide consultants and employees of the Corporation issued pursuant to a Board-approved option or incentive plan including the Corporation’s 2006 Stock Incentive Plan in an amount not
to exceed 83,272 shares of Common Stock in the aggregate (as adjusted from time-to-time in the event of any stock dividend or distribution, stock split, reverse stock split or combination or other similar pro rata recapitalization event affecting
any class or series of Common Stock), (ii) stock, warrants or other securities issued to a bank or other financial institution in connection with a financing, not to exceed five percent (5%) of the issued and outstanding shares of Common
Stock in the aggregate, (iii) shares of Common Stock issuable upon conversion of the Series A Convertible Preferred Stock, (iv) shares of Common Stock issued in connection with any acquisition by the Corporation approved by the Board
(including at least one director nominated pursuant to Section 2.1(b)(i) or 2.1(b)(ii) of this Agreement), (v) shares of Common Stock issued by the Corporation in a QIPO, (vi) Equity Securities of the Corporation issued after the date
hereof to give effect to any stock dividend or distribution, stock split, reverse stock split or combination or other similar pro rata recapitalization event affecting any class or series of Common Stock, and (vii) securities of the Corporation
that are redeemable by the Corporation upon a date certain by the Corporation but are not Common Stock Equivalents. 
 “Fair Market
Value” shall have the meaning set forth in Section 3.3(d) hereof. 
 “Financing Documents” shall have the
meaning set forth in Section 3.3(e) hereof. 
 “For Cause Repurchase Right” shall have the meaning set forth in
Section 3.3(a) hereof. 
 “Freeport” means Freeport Loan Fund LLC and any Permitted Transferee thereof. 
 “Future Stockholder” shall have the meaning set forth in Section 3.1 hereof. 
 “Governmental Entity” has the meaning ascribed to such term in the Purchase Agreement. 
 “Group” means: 
 (a) in the
case of any Stockholder who is an individual, (i) such Stockholder, (ii) the spouse, parent, sibling or lineal descendants of such Stockholder, (iii) all trusts for the benefit of such Stockholder or any of the foregoing,
(iv) all Persons principally owned by and/or organized or operating for the benefit of any of the foregoing, and (v) all Affiliates of such Stockholder; 
  

 3 

 (b) in the case of any Stockholder that is a partnership, (i) such Stockholder, (ii) its
limited, special and general partners, (iii) any Person to which such Stockholder shall Transfer all or substantially all of its assets or with which it shall be merged, and (iv) all Affiliates and employees of and consultants to, such
Stockholder; and 
 (c) in the case of any Stockholder which is a corporation or a limited liability company, (i) such Stockholder,
(ii) its stockholders or members as the case may be, (iii) any Person to which such Stockholder shall Transfer all or substantially all of its assets, and (iv) all Affiliates of such Stockholder. 
 “Independent Directors” shall have the meaning set forth in Section 2.1(b)(iv) hereof. 
 “Initial Subscribing Investor” shall have the meaning set forth in Section 3.5(f) hereof. 
 “Investor Directors” means the Eos Capital Director, the Eos SBIC Directors and the Additional Investor Directors, if any. 

“Investor Nominee” shall have the meaning set forth in Section 3.7(c) hereof. 
 “Investors” means the Persons set forth on Annex I hereto and any Person who becomes a party to this Agreement as an Investor
pursuant to Section 3.1 or 3.2. 
 “Investor Shares” means all Equity Securities of the Corporation held at any time
during the term of this Agreement by the Investors. 
 “Joinder Agreement” shall have the meaning set forth in
Section 3.1 hereof. 
 “Liquidation” shall have the meaning set forth in the Charter. 
 “Major Management Stockholder” means any Management Stockholder that owns (i) more than 10% of all the outstanding Common Stock
Equivalents or (ii) more than 50% of all the outstanding Common Stock Equivalents owned by all Management Stockholders (so long as at least 50% of the Original Management Stockholder Shares remain outstanding). 
 “Majority in Interest” means, (i) with respect to the Investor Shares, the holders of at least a majority of the Investor Shares
then outstanding and (ii) with respect to the Management Stockholder Shares, the holders of at least a majority of the Management Stockholder Shares then outstanding, and, if applicable, the Original Management Stockholder Threshold.

  

 4 

 “Management Agreement” means that certain Management and Consulting Agreement dated as
of the date hereof between Addus HealthCare, Inc. and Eos Management, Inc. (as it may be amended, restated, supplemented or otherwise modified from time-to-time). 
 “Management Directors” shall have the meaning set forth in Section 2.1(b)(iii) hereof. 
 “Management Stockholder” means the Persons set forth on Annex II hereto and any Person who becomes a party to this Agreement as a Management Stockholder pursuant to Section 3.1 or 3.2. 
 “Management Stockholder Shares” means all Equity Securities held at any time during the term of this Agreement by the Management
Stockholders. 
 “NASDAQ” means the National Association of Securities Dealers Automated Quotations. 
 “New Securities” means all Equity Securities other than Excluded Stock. 
 “Observer” shall have the meaning set forth in Section 2.6(a). 
 “Offer Notice” shall have the meaning set forth in Section 3.6(a). 
 “Offerees” shall have the meaning set forth in Section 3.6(a). 
 “Original Management Stockholder Shares” means the Management Stockholder Shares outstanding on the date hereof. 
 “Original Management Stockholder Threshold” means the holders of a majority of the Original Management Stockholder Shares so long as at
least fifty percent (50%) of the Original Management Stockholder Shares remain outstanding. 
 “Original Purchase
Price” means One Hundred Dollars ($100) per share (subject to pro rata adjustment in the event of any stock split, stock dividend or other subdivision of the Equity Securities or other similar pro rata recapitalization event effecting the
Equity Securities). 
 “Other Accredited Stockholders” shall have the meaning set forth in Section 3.5(f) hereof.

 “Other Stockholders” shall have the meaning set forth in Section 3.4(a)(i) hereof. 
 “Permitted Family Transferee” means, with respect to any Management Stockholder (and each Permitted Transferee of such Management
Stockholder), (i) the spouse, sibling or any lineal descendant (including adopted children) of such Person, (ii) any trust solely for the benefit of such Person and/or the spouse or lineal descendants (including adopted children) of such
Person, (iii) a charitable foundation under the Control of such Person, (iv) a family trust, partnership or limited liability company under the Control of such Person or established solely for the benefit of such Person and/or such
Person’s spouse or lineal 

  

 5 

 
descendants (including adopted children) or for estate planning purposes provided such family trust, partnership or limited liability company remains under
the Control of such Person, or (v) the estate of such Person. 
 “Permitted Transfer” means (a) with respect to a
Management Stockholder, any Transfer by such Management Stockholder to (i) a Permitted Family Transferee of such Management Stockholder, (ii) any Transferee approved in writing by the Investors holding a majority of the Investor Shares
outstanding at such time or (iii) any other Management Stockholder or any Permitted Family Transferee of such Management Stockholder, (b) with respect to a Stockholder who is an Investor, any Transfer by such Investor to a member of such
Investor’s Group and (c) with respect to W. Andrew Wright, III, any transfer to an officer of the Corporation not to exceed up to five officers in the aggregate. 
 “Permitted Transferee” means any Person to whom a Permitted Transfer is made. 
 “Person” shall be construed as broadly as possible and shall include an individual or natural person, a partnership (including a limited
liability partnership), a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization or a Governmental Entity. 
 “Preemptive Offer” shall have the meaning set forth in Section 3.5(a) hereof. 
 “Preemptive Offer Notice” shall have the meaning set forth in Section 3.5(a) hereof. 
 “Preemptive Offer Number” shall have the meaning set forth in Section 3.5(b) hereof. 
 “Preemptive Offer Period” shall have the meaning set forth in Section 3.5(a) hereof. 
 “Preferred Stock” shall have the meaning set forth in the Charter. 
 “Prevailing Party” means, in an action seeking (i) monetary damages, a party securing as a final judgment, a dollar amount
(excluding interest) that is equal to or greater than fifty percent (50%) of the amount claimed as damages in the complaint or as a counterclaim in the answer, and, if such party fails to secure an amount equal to or greater than fifty percent
(50%) of the amount claimed, then the other party shall be deemed to be the prevailing party for purposes of this Agreement; (ii) a declaratory ruling or a permanent injunction, a party successfully securing the relief sought, and, if such
party is unsuccessful securing such relief, then the other party shall be deemed to be the prevailing party; and (iii) monetary damages and a demand for a declaratory ruling or permanent injunction, a party satisfying the criteria in both
clauses (i) and (ii), and, if such party does not satisfy such criteria, then the other party shall be deemed to be the prevailing party; provided, however, if one party would be a prevailing party under one of the clauses in this
definition and the other party would be a prevailing under another clause, then neither party shall be deemed a prevailing party for purposes of this Agreement. 
  

 6 

 “Pro Rata Amount” means, with respect to any Stockholder, the quotient obtained by
dividing (i) the number of Common Stock Equivalents held by such Stockholder by (ii) the aggregate number of Common Stock Equivalents held by all Stockholders or class of Stockholders (as applicable); provided, however, that
“out-of-the-money” stock options shall not be deemed Common Stock Equivalents for purposes of calculating the Pro Rata Amount. 
 “Public Offering” shall mean the offering of Common Stock on a public exchange. 
 “Purchase
Agreement” means that certain Stock Purchase Agreement dated as of September 19, 2006 by and among the Corporation, Addus Management Corporation, Addus Acquisition Corporation, Addus HealthCare, Inc., W. Andrew Wright, III, as
Sellers’ Representative, and the sellers set forth on Exhibit A thereto (as the same may be amended, restated or otherwise modified from time-to-time). 
 “Purchase Notice” shall have the meaning set forth in Section 3.5(b) hereof. 
 “QIPO” means the consummation of the first firm commitment underwritten public offering pursuant to an effective registration statement filed on Form S-1 (or its successor form) under the Securities Act resulting in
aggregate proceeds (net of underwriting discounts and commissions) to the Corporation of not less than Fifty Million Dollars ($50,000,000). 
 “Refusal Shares” shall have the meaning set forth in Section 3.6(a) hereof. 
 “Registration Rights
Agreement” means that certain Registration Rights Agreement dated as of the date hereof among the Corporation and the Stockholders (as amended, modified or supplemented from time-to-time). 
 “Regulatory Agreement” means that certain Regulatory Agreement dated as of the date hereof among the Corporation and Eos SBIC III (as
amended, modified or supplemented from time-to-time). 
 “Related Person” shall have the meaning set forth in
Section 4.1 hereof. 
 “Representative” shall have the meaning set forth in Section 6.3(b). 
 “Repurchase Disability” shall have the meaning set forth in Section 3.3(e) hereof. 
 “Repurchase Date” shall have the meaning set forth in Section 3.3(b) hereof. 
 “Repurchase Notice” shall mean the notice provided by the Corporation to a Management Stockholder (or a Permitted Transferee of such
Management Stockholder) in connection with the Corporation’s exercise of a Repurchase Right. 
 “Repurchase Price”
shall have the meaning set forth in Section 3.3(b) hereof. 
 “Repurchase Price Adjustment” shall have the meaning set
forth in Section 3.3(b) hereof. 
  

 7 

 “Repurchase Right” shall have the meaning set forth in Section 3.3(a) hereof.

 “Sale of the Corporation” shall have the meaning set forth in the Charter. 
 “Securities Act” means the Securities Act of 1933, as amended, or any successor federal statute, and the rules and regulations
promulgated thereunder. 
 “Seller” shall have the meaning set forth in Section 3.6(a) hereof. 
 “Series A Preference Amount” shall have the meaning set forth in the Charter. 
 “Series A Preferred Stock” means the Corporation’s Series A Convertible Preferred Stock, $0.001 par value per share. 
 “Shares” means all Investor Shares and all Management Stockholder Shares. 
 “Stockholders” means the Investors, the Management Stockholders and any Future Stockholders. 
 “Stock Incentive Plan” means the Corporation’s 2006 Stock Incentive Plan (as such plan may be amended, restated or otherwise
modified from time-to-time). 
 “Subscribing Stockholders” shall have the meaning set forth in Section 3.5(a) hereof.

 “Subsidiary” means, with respect to any Person, any other Person the majority of whose Equity Securities or voting
securities are directly or indirectly owned or controlled by such Person. 
 “Subsidiary Governing Body” shall have the
meaning set forth in Section 2.6(b) hereof. 
 “Tag Along Notice” shall have the meaning set forth in
Section 3.4(c) hereof. 
 “Termination Date” means the earlier to occur of: (i) the closing of a QIPO and
(ii) the closing of a Liquidation. 
 “Termination of Employment for Cause” shall mean termination relating to
(i) the conviction of a crime involving fraud, theft or dishonesty by the Management Stockholder; (ii) the Management Stockholder’s willful and continuing disregard of lawful instructions of the Board or superiors (if any), or the
Management Stockholder’s willful misconduct in carrying out his or her position and duties of employment; (iii) the use of alcohol or drugs by the Management Stockholder to an extent that such use interferes in any manner with the
performance of the Management Stockholder’s duties and responsibilities as an employee of the Corporation; (iv) the failure by the Management Stockholder to observe material Corporation policies generally applicable to employees of the
Corporation, or (v) the conviction of the Management Stockholder for violating any law constituting a felony (including the Foreign Corrupt Practices Act of 1977). 
  

 8 

 “Third Party” means, with respect to any Stockholder, any Person that is not
(i) the Corporation or (ii) a member of the Group of such Stockholder. 
 “Transfer” means to sell, transfer,
assign, pledge, hypothecate or otherwise dispose of Equity Securities, either voluntarily or involuntarily and with or without consideration excluding by Management Stockholders to the Corporation upon a termination of employment or by any Investors
to the Corporation. 
 “Transferee” means any Person to whom a Stockholder shall Transfer Shares. 
 ARTICLE II 
 BOARD REPRESENTATION

  

	2.1.	Board Representation. 

 (a) The Corporation
and the Stockholders shall take such corporate actions as may be required to ensure that (i) the number of directors constituting the Board is at all times no greater than eight (8) (subject to increase pursuant to the Board Expansion
Option), and (ii) the presence of at least two (2) Investor Directors is required to constitute a quorum of the Board. The Board shall initially be set at five (5) members. 
 (b) The Board shall be comprised as follows: 
 (i) Subject to clause (vi) below, Eos Capital shall be entitled: (A) to nominate two (2) individuals to the Board to serve as directors (the “Eos Capital Directors”) until their
respective successors are elected and qualified, (B) to nominate each successor to the Eos Capital Directors and (C) to direct the removal from the Board of any director nominated under the foregoing clauses (A) or (B); the Eos
Capital Directors shall initially be Brian Young and Mark L. First; 
 (ii) Subject to clause (vi) below, Eos SBIC III
shall be entitled: (A) to nominate one (1) individual to the Board to serve as director (the “Eos SBIC Director”) until his respective successor is elected and qualified, (B) to nominate each successor to the Eos SBIC
Director and (C) to direct the removal from the Board of any director nominated under the foregoing clauses (A) or (B); the Eos SBIC Director shall initially be Simon Bachleda; 
 (iii) Subject to Section 2.1(d), a Majority in Interest of the Management Stockholders, so long as they continue to own, directly or
indirectly, at least fifty percent (50%) of the Management Stockholder Shares owned by them in the aggregate on the date hereof, shall be entitled: (A) to nominate two (2) individuals to the Board to serve as directors (each, a
“Management Director”, and together the “Management Directors”) until their respective successors are elected and qualified, (B) to nominate each successor to the Management Directors and (C) to direct the
removal from the Board of any director nominated under the foregoing clauses (A) or (B); provided, however, that if the Management Stockholders continue to own, directly or indirectly, less than fifty percent (50%) but at
least twenty-five percent (25%) of the 

  

 9 

 
Management Stockholder Shares owned by them in the aggregate on the date hereof, a Majority in Interest of the Management Stockholders shall be entitled to
nominate only one (1) Management Director to the Board. For purposes of clarification, if the Management Stockholders own, directly or indirectly, less than twenty-five percent (25%) of the Management Stockholder Shares owned by them in
the aggregate on the date hereof, they shall no longer be entitled to nominate a Management Director to the Board. The Management Directors shall initially be W. Andrew Wright, III and Mark S. Heaney; 
 (iv) a majority of the Investor Directors and the Management Directors (that includes the vote of at least one (1) Management
Director) acting together shall be entitled: (A) to nominate up to three (3) individuals to the Board to serve as directors (the “Independent Directors”) until their respective successors are elected and qualified,
(B) to nominate each successor to the Independent Directors and (C) to direct the removal from the Board of any director nominated under the foregoing clauses (A) or (B); provided, however, that such nominee and any
successor may not be (x) an officer or employee of the Corporation, (y) any Management Stockholder or (z) any Investor, and shall be knowledgeable in the Corporation’s industry; 
 (v) upon the occurrence of the Board Expansion Option in accordance with Section 2.8, a Majority in Interest of the Investors shall
be entitled: (A) to nominate up to three (3) individuals to the Board to serve as directors (the “Additional Investor Directors”) until their respective successors are elected and qualified, (B) to nominate each
successor to the Additional Investor Directors and (C) to direct the removal from the Board of any Additional Investor Director nominated under the foregoing clauses (A) or (B); and 
 (vi) For so long as the Eos Entities have not received their aggregate Series A Preference Amount, the Eos Entities shall continue to
retain the rights set forth in Section 2.1(b)(i), Section 2.1(b)(ii), Section 2.1(b)(v) and Section 2.8. At such time as the Eos Entities have been paid their aggregate Series A Preference Amount in full, the following provisions
shall apply: 
  

	 	(A)	so long as the Investors continue to own, directly or indirectly, at least twenty-five percent (25%) of the Investor Shares owned by them in the aggregate on the date hereof,
Section 2.1(b)(i), Section 2.1(b)(ii), Section 2.1(b)(v) and Section 2.8 shall remain in full force and effect; 

  

	 	(B)	so long as the Investors continue to own, directly or indirectly, at least five percent (5%) but less than twenty-five percent (25%) of the Investor Shares owned by them
in the aggregate on the date hereof, (x) Section 2.1(b)(ii) shall remain in full force and effect, (y) Section 2.1(b)(i)(A) shall be amended such that Eos Capital shall only be entitled to nominate (and remove) one
(1) individual to the Board to serve as a director and (z) Section 2.1(b)(v) and the Board Expansion Option set forth in Section 2.8 shall terminate and be of no further force and effect; and 

  

 10 

	 	(C)	if the Investors own, directly or indirectly, less than five percent (5%) of the Investor Shares owned by them in the aggregate on the date hereof, the Eos Entities shall no
longer be entitled to nominate any individuals to the Board. 

 (c) Each nomination or any proposal to remove from the Board
any director shall be made by delivering to the Corporation a notice signed by the party or parties entitled to such nomination or proposal. As promptly as practicable, but in any event within ten (10) days, after delivery of such notice, the
Corporation shall take or cause to be taken such corporate actions as may be reasonably required to cause the election or removal proposed in such notice. Such corporate actions may include calling a meeting or soliciting a written consent of the
Board, or calling a meeting or soliciting a written consent of the Stockholders. 
 (d) Notwithstanding anything to the contrary contained
herein, the Management Stockholders may not appoint an individual other than (i) W. Andrew Wright, III, (ii) Mark S. Heaney or (iii) any individual set forth on Annex III hereto, as a Management Director without the prior written
consent of Eos Capital, which consent shall not be unreasonably withheld. 
  

	2.2.	Voting Agreement. 

 (a) Each Stockholder
covenants and agrees to vote all Equity Securities held by such Stockholder for (i) the election to the Board of all individuals nominated in accordance with Section 2.1 and for the removal from the Board of all directors proposed to be
removed in accordance with Section 2.1, and (ii) the election to each committee of the Board of the Investor Directors and the Management Directors nominated in accordance with Section 2.4, and in each case shall take all actions
required on its behalf to give effect to the agreements set forth in this Article II. Each Stockholder shall use its respective best efforts to cause each director originally nominated by such Stockholder to vote for the election to the Board of all
individuals nominated in accordance with Section 2.1. 
 (b) Pursuant to this Section 2.2, each undersigned Stockholder hereby
approves and votes all of his, her or its Equity Securities in favor of the election to the Board of each of the initial designees named pursuant to Section 2.1(b) above. 
 (c) Each Management Stockholder hereby delivers to Eos Capital an irrevocable proxy, coupled with an interest, authorizing Eos Capital to act as proxy of
such Management Stockholder solely in connection with such Management Stockholder’s agreements contained in this Article II, with full powers of substitution and resubstitution, and hereby authorizes Eos Capital to vote, give consents and in
all other ways act in such Management Stockholder’s place with respect to all Management Stockholder Shares held by such Management Stockholder (and any and all other Equity Securities issued in respect thereof) solely in connection with such
Management Stockholder’s agreements contained in this Article II, which proxy shall be valid and remain in effect until the provisions of this Article II expire; provided, however, that a Management Stockholder’s ability to
vote to appoint or remove a Management Director or appoint or remove an Independent Director shall not be subject to the irrevocable proxy, interest or authority delivered in this Section 2.2(c). 
  

 11 

	2.3.	Interim Director. 

 The Corporation shall
notify each Stockholder of the occurrence of any vacancy in any seat of the Board. If the Stockholders entitled to nominate a successor to fill such vacancy fail to do so within fifteen (15) days after delivery of such notice, such vacancy may
be filled in accordance with the Bylaws (subject in all cases to Section 2.5(b) below) until a successor has been nominated and elected to the Board in accordance with Sections 2.1 and 2.2 of this Agreement. 
  

	2.4.	Committees; Subsidiaries. 

 (a) Each
Stockholder shall use its respective best efforts to cause each director of the Corporation originally nominated by such Stockholder to take such corporate actions as may be reasonably required to ensure that each committee of the Board contains at
least one (1) Investor Director and one (1) Management Director. 
 (b) The Investor Directors and the Management Directors shall
have the right (but not the obligation) to cause the Corporation and each Stockholder to take, and each Stockholder shall use its respective best efforts to cause each director of the Corporation originally nominated by such Stockholder to take,
such corporate actions as may be reasonably required to ensure that the composition of the board of directors (or similar governing body) of all direct and indirect Subsidiaries of the Corporation is identical to the composition of the Board.

  

	2.5.	Vacancies and Removal. 

 (a) The directors
designated in Section 2.1(b) will be elected at any annual or special meeting of the Stockholders (or by written consent in lieu of a meeting of the Stockholders) and will serve until their successors are duly elected and qualified or until
their earlier resignation or removal. 
 (b) The Corporation shall notify each Stockholder of the occurrence of any vacancy in any seat of
the Board. Subject to the foregoing regarding the appointment of directors, in the event a vacancy is created on the Board by reason of the death, disability, removal (with or without Cause) or resignation of any director, each of the directors
hereby agrees that (i) such vacancy shall be filled in accordance with the procedures set forth in Section 2.1 and (ii) no Stockholder shall have the ability to fill any vacancy to the extent that the ability to appoint such
Stockholder is specifically granted to other Stockholders pursuant to Section 2.1. No Stockholder shall have the ability to remove a director to the extent that such director was not nominated by such Stockholder (other than in the case where a
director is removed as a result of being terminated by the Corporation for Cause, in which case the vacancy created thereby will again be filled by the Stockholders entitled to nominate such director). 
 (c) No Person may serve as a director to the extent such Person has been terminated by the Corporation for Cause. 
  

 12 

	2.6.	Non-Voting Observers. 

 (a) In addition to
their other rights under this Agreement, (i) the Eos Entities shall be entitled to have an unlimited number of non-voting observers and (ii) if, pursuant to Section 2.1(d), the Management Stockholders appoint a Management Director
other than W. Andrew Wright, III or Mark S. Heaney, each such Management Director shall be entitled to have one (1) non-voting observer (collectively, the “Observers”) who shall be designated by the applicable Eos Entity, or
the Management Director, as applicable, in its sole discretion, by notice to the Corporation from time to time (and who shall also be subject to removal for no reason or any reason whatsoever by such Eos Entity or Management Director, as applicable,
by notice to the Corporation from time to time). 
 (b) Each Observer shall be entitled to be present at all meetings of the Board (and each
committee thereof that the designating director is a member of) (each, a “Corporation Governing Body”), as well as at all meetings of the board of directors (or similar governing body) of all direct and indirect Subsidiaries of the
Corporation (and each committee thereof that the designating director is a member of) (each, a “Subsidiary Governing Body”). The Corporation shall notify each Observer of each meeting of each Corporation Governing Body and each
meeting of each Subsidiary Governing Body, including the time and place of such meeting, in the same manner and at the same times as the members of such Corporation Governing Body or Subsidiary Governing Body, as the case may be, are notified.

 (c) Each Observer shall (i) have the same access to information concerning the business and operations of the Corporation and its
Subsidiaries, including, but not limited to, notes, minutes and consents, at the same times as the members of each Corporation Governing Body or Subsidiary Governing Body may receive access to such information, (ii) be entitled to participate
in discussions of the affairs, finances and accounts of, and consult with, and make proposals and furnish advice to, the Corporation Governing Bodies and the Subsidiary Governing Bodies, and the members of the Corporation Governing Bodies and the
Subsidiary Governing Bodies and the Corporation shall use its reasonable best efforts to cause the officers of the Corporation and its Subsidiaries to take such proposals or advice seriously and give due consideration thereto, provided, that
nothing herein is intended to require compliance with any such proposal or advice or to impose liability for any failure so to comply, and (iii) be provided with copies of all notices, minutes, consents, and forms of consents in lieu of
meetings of the Corporation Governing Bodies and the Subsidiary Governing Bodies and all other material that the Corporation or any of its Subsidiaries provides to members of any Corporation Governing Body or Subsidiary Governing Body as such, in
each case at the same time or times as such notices, minutes, consents or forms are issued or circulated by or to, or such other material is provided to, such members. A majority of the Board shall have the right to exclude any Observer from
portions of meetings of the Board or omit to provide any Observer with certain information if such members of the Board believe that (i) access to such information could be reasonably expected to adversely affect the attorney-client privilege
between the Corporation and its counsel, or (ii) such disclosure is prohibited by an agreement with a third party; provided, however, that in the case of the preceding clause (ii), the Corporation will use commercially reasonable
efforts to provide such documentation, which requirement shall be satisfied if the Observer is offered the opportunity to obtain such documentation by executing or otherwise becoming a party to the confidentiality restrictions on substantially the
same terms (including 

  

 13 

 
any standstill provisions) as are applicable to the Corporation. Notwithstanding anything to the contrary contained in this Agreement, an Observer may not
use or disclose any information received by such Observer, unless and except to the extent that such use or disclosure could have been made by a director of the Corporation in compliance with all laws and duties applicable to a director as such
under such circumstances. 
  

	2.7.	Meetings; Expenses. 

 (a) The Corporation
shall convene meetings of the Board at least once every three months. Upon any failure by the Corporation to convene any meeting required by this paragraph, an Investor Director or Management Director shall be empowered to convene such meeting.

 (b) The Corporation shall (i) reimburse each Director and each Observer for his or her reasonable out-of-pocket expenses (including
travel) incurred in connection with the attendance of meetings of the Board or any committee thereof and (ii) reimburse each Director for his or her reasonable out-of-pocket expenses (including travel) incurred in connection with conducting any
other business of the Corporation (or any subsidiary thereof). 
  

	2.8.	Board Expansion Option. 

 Subject to
Section 2.1(b)(vi), a Majority in Interest of the Investors may, in their sole discretion and at any time, by written notice to the Corporation, increase the number of directors constituting the Board up to eleven (11) and designate
Additional Investor Directors to the Board in accordance with Section 2.1(b)(v) (such election, the “Board Expansion Option”). 
 ARTICLE III 
 ISSUANCE AND TRANSFER OF SHARES 
  

	3.1.	Future Stockholders. 

 The Corporation shall
require each Person that acquires Equity Securities (excluding options to acquire Common Stock) after the date hereof (a “Future Stockholder”), as a condition to the effectiveness of such acquisition, to execute a joinder to this
Agreement, substantially in the form attached hereto as Exhibit A (the “Joinder Agreement”), agreeing to be treated as (i) an Investor, if such Person acquires such Equity Securities from an Investor, (ii) a
Management Stockholder, if such Person acquires such Equity Securities from a Management Stockholder, or (iii) a Management Stockholder, if such Person is not otherwise an Investor and acquires Equity Securities from the Corporation, whereupon,
in each case, such Person shall be bound by, and entitled to the benefits of, the provisions of this Agreement relating to Investors or Management Stockholders, as the case may be. The parties hereto agree to take all actions to permit the
Corporation to comply with all of its obligations under all agreements with the Stockholders. 
  

	3.2.	Limitations on Transfers. 

 (a) No Transfer
of any Equity Securities by any Stockholder shall become effective unless and until (i) the transferee (unless already subject to this Agreement) executes 

  

 14 

 
and delivers to the Corporation a Joinder Agreement, agreeing to be treated in the same manner as the transferring Stockholder (i.e., as either an Investor
or a Management Stockholder) and (ii) such Transfer is either (x) a Permitted Transfer or (y) otherwise made in compliance with this Article III. Upon such Transfer and such execution and delivery, the Transferee shall be bound by,
and entitled to the benefits of, this Agreement with respect to the transferred Equity Securities in the same manner as the transferring Stockholder. The provisions regarding Transfers of Equity Securities contained in this Article III shall apply
to all Equity Securities now owned or hereafter acquired by a Stockholder. Any Transfer of Equity Securities by a Stockholder not made in accordance with this Article III shall be void ab initio. 
 (b) Notwithstanding anything to the contrary contained herein, no Stockholder may Transfer any Equity Securities to any Person (or to any Affiliate
thereof), other than in connection with an Approved Sale, who directly or indirectly competes with the Corporation or any of the Corporation’s Subsidiaries, as determined in good faith by the Board. 
 (c) Each Stockholder shall, after complying with the provisions of this Agreement, but prior to any Transfer of Equity Securities, give written notice to
the Corporation of such proposed Transfer. Each such notice shall describe the manner and circumstances of the proposed Transfer. Upon request by the Corporation, each Stockholder seeking to Transfer Equity Securities shall deliver a written
opinion, addressed to the Corporation, of counsel for such Stockholder, stating that in the opinion of such counsel (which opinion and counsel shall be reasonably satisfactory to the Corporation) such proposed Transfer does not involve a transaction
requiring registration or qualification of such Equity Securities under the Securities Act or the securities laws of any State of the United States; provided, however, that no such opinion shall be required for a Transfer which is a Permitted
Transfer or a Transfer effected pursuant to Sections 3.3, 3.4, 3.5(f), 3.6 or 3.7 hereof. Subject to compliance with the other provisions of this Agreement, if the Corporation does not request such an opinion within ten (10) Business Days of
receipt of the notice, the Transferring Stockholder shall be entitled to Transfer such Equity Securities, on the terms set forth in the notice, within sixty (60) days of delivery of the notice. 
 (d) Notwithstanding anything to the contrary contained herein, no Management Stockholder shall be permitted to Transfer all or any part of its Equity
Securities to any Person prior to the date that is five (5) years from the date hereof, other than (i) to Permitted Transferees, (ii) pursuant to Sections 3.3, 3.4, 3.5(f) or 3.7 or (iii) with the written consent of Eos Capital
(which consent may be withheld in the sole discretion of Eos Capital). 
 (e) Each Stockholder that is an entity that was formed for the sole
purpose of directly or indirectly acquiring Equity Securities or that has no substantial assets other than Equity Securities or direct or indirect interests in Equity Securities agrees that (i) certificates for shares of its common stock or
other instruments reflecting equity interests in such entity (and the certificates for shares of common stock or other equity interests in any similar entities controlling such entity) will note the restrictions contained in this Agreement on the
restrictions on transfer of shares as if such common stock or other equity interests were Equity Securities, (ii) no shares of such common stock or other equity interests may be transferred to any person other than in accordance with the terms
and provisions of this Agreement as if such common stock or other equity interests were Equity Securities and (iii) any transfer of such common stock or other equity interests shall be deemed to be a transfer of a pro rata number of
Equity Securities hereunder. 
  

 15 

	3.3.	Repurchase Right. 

 (a) Management
Stockholder Terminated for Cause. In the event that a Management Stockholder’s employment with the Corporation is terminated for Cause at any time after the date hereof, the Corporation (or its designee) shall have the right (but not the
obligation), upon delivery of a Repurchase Notice to such Management Stockholder, to repurchase from such Management Stockholder (and any member of such Management Stockholder’s Group and each of such Management Stockholder’s Permitted
Transferees) all or any part of the Management Stockholder Shares owned by such Management Stockholder (and each of such Management Stockholder’s Permitted Transferees) at any time (a “Repurchase Right”). 
 (b) Payment of the Repurchase Price. The purchase price payable by the Corporation upon exercise of a Repurchase Right (“Repurchase
Price”) shall be the greater of (i) Fair Market Value (as defined below) of the Management Stockholder Shares subject to the Repurchase Right on the date of termination of such Management Stockholder’s employment with the
Corporation and (ii) the Original Purchase Price. The closing of the repurchase shall occur no later than ninety (90) days following the delivery of the Repurchase Notice (the “Repurchase Date”). Notwithstanding the
foregoing, if (x) a Management Stockholder is terminated for Cause for reasons other than the conviction of a felony or a crime involving fraud, theft or dishonesty, (y) the Corporation consummates a Public Offering or Sale of the
Corporation within twelve (12) months of such date of termination, and (z) the Fair Market Value of such Management Stockholder Shares that would have been realized had such Management Stockholders still owned such Management Stockholder
Shares upon the consummation of such Public Offering or Sale of the Corporation, as applicable, is greater than the Repurchase Price that was determined pursuant to the first sentence of this Section 3.3(b), then, within thirty (30) days
of the consummation of such Public Offering or Sale of the Corporation, as the case may be, the Corporation shall pay such Management Stockholder the difference between such greater value and the Repurchase Price amount actually paid to such
Management Stockholder (the “Repurchase Price Adjustment”). The Repurchase Price and, if applicable, the Repurchase Price Adjustment, shall be paid in cash (subject to the limitations set forth in Section 3.3(e) below);
provided, however, that if such Repurchase Right is being exercised pursuant to Section 3.3(a) above due to such Management Stockholder’s conviction of a felony or a crime involving fraud, theft or dishonesty, the Corporation
shall have the option, in its sole discretion, to pay the Repurchase Price and the Repurchase Price Adjustment by issuing to such Management Stockholder an unsecured subordinated promissory note in lieu of cash, the terms and conditions of which
shall be determined in good faith by the Board. 
 (c) Procedures. On the Repurchase Date, the Management Stockholder shall transfer
the Management Stockholder Shares subject to the Repurchase Notice to the Corporation, free and clear of all liens and encumbrances, by delivering to the Corporation the certificates representing the Management Stockholder Shares to be purchased,
duly endorsed for transfer to the Corporation or accompanied by a stock power duly executed in blank, and the Corporation shall pay to the Management Stockholder the Repurchase Price. The Corporation 

  

 16 

 
and the Management Stockholder each shall use his, her or its reasonable efforts to expedite all proceedings contemplated hereunder to obtain a determination
of the Repurchase Price of the Management Stockholder Shares at the earliest practicable date. 
 (d) “Fair Market Value”.
For purposes of this Section 3.3, the “Fair Market Value” of Management Stockholder Shares, as of any date of determination, shall be determined as follows: 
 (i) If such Management Stockholder Shares are listed on one or more national securities exchanges (within the meaning of the Securities
Exchange Act of 1934, as amended), each such Management Stockholder Share so listed to be repurchased shall be valued at the closing price of such Management Stockholder Share on the principal exchange on which such shares are then trading on the
most recent trading day preceding such date of determination; 
 (ii) If such Management Stockholder Shares are not traded on
a national securities exchange but the Corporation is quoted on NASDAQ or a successor quotation system and such Management Stockholder Shares are listed as a national market issue under the NASD National Market System, each such Management
Stockholder Share to be repurchased shall be valued at the mean between the closing representative bid and asked prices for such Management Stockholder Share on the most recent trading day preceding such date of determination as reported by NASDAQ
or such successor quotation system; or 
 (iii) If such Management Stockholder Shares are not publicly traded on a national
securities exchange and are not quoted on NASDAQ or a successor quotation system, the Fair Market Value of such Management Stockholder Shares to be repurchased shall be an amount determined in good faith by the Board. In the event that the affected
Management Stockholder reasonably disagrees with the Board’s determination of the Fair Market Value of the Management Stockholder Shares subject to the Repurchase Right, such Management Stockholder shall have the right to an appraisal of such
Management Stockholder Shares by a mutually acceptable independent accounting firm, the expense of which shall be borne by the Corporation, and the Fair Market Value determination of such appraisal shall be conclusive and binding (absent fraud or
manifest error). 
 (e) Repurchase Rights Prohibited. Notwithstanding anything to the contrary herein, in the event that the
Corporation shall not be permitted to purchase any Management Stockholder Shares upon exercise of a Repurchase Right because: (A) the purchase of Management Stockholder Shares would render the Corporation or its Subsidiaries unable to meet
their obligations in the ordinary course of business taking into account any pending or proposed transactions, capital expenditures or other budgeted cash outlays by the Corporation, including, without limitation, any proposed acquisition of any
other entity by the Corporation or any of its Subsidiaries; (B) the Corporation is prohibited from purchasing the Management Stockholder Shares by applicable law restricting the purchase by a corporation of its own shares or would cause or make
it likely that the Corporation would become the subject of a federal bankruptcy proceeding or would otherwise cause the Corporation to become insolvent; or (C) the purchase 

  

 17 

 
of Management Stockholder Shares would constitute a breach of, default, or event of default under, or is otherwise prohibited by, the terms of any loan
agreement or other agreement or instrument to which the Corporation or any of its Subsidiaries is a party (the “Financing Documents”) or the Corporation is not able to obtain the requisite consent of any of its lenders to the
purchase of the Shares (each of the events described in (A) through (C) above being a “Repurchase Disability”), then the Corporation shall provide written notice to the Management Stockholder with respect to whom the
Repurchase Right has been exercised (a “Disability Notice”) specifying the nature of the Repurchase Disability. The Corporation shall thereafter have the right (but not the obligation) to repurchase the Management Stockholder Shares
described in the Repurchase Notice as soon as reasonably practicable after all Repurchase Disabilities cease to exist (or, in the case of a Management Stockholder terminated for Cause due to such Management Stockholder’s conviction of a crime
involving fraud, theft or dishonesty, the Corporation may elect, but shall have no obligation, to issue a subordinated promissory note to such Management Stockholder, the terms and conditions of which shall be determined in good faith by the Board).

  

	3.4.	Co-Sale Rights. 

 (a) Subject to compliance
with the other applicable provisions of this Agreement, if at any time an Investor (the “Co-Sale Transferor”) proposes to Transfer any Investor Shares (other than pursuant to a Permitted Transfer) to any Third Party (the
“Co-Sale Transferee”), the Co-Sale Transferor shall, at least thirty (30) days prior to the closing of such Transfer: 
 (i) Deliver a notice (the “Co-Sale Notice”) to all other Stockholders that hold Equity Securities (the “Other Stockholders”) detailing the terms and conditions of the proposed
Transfer; provided, however, that such Co-Sale Notice shall indicate that the Co-Sale Transferee has been informed of the co-sale rights provided for in this Section 3.4 and has agreed to purchase Equity Securities in accordance
with the terms hereof. 
 (ii) The Co-Sale Transferor shall not be permitted to Transfer any Equity Securities to the Co-Sale
Transferee unless the Other Stockholders are permitted to Transfer their respective Pro Rata Amount of the aggregate number of Equity Securities to which the co-sale offer relates. 
 (b) The Co-Sale Transferor shall, in addition to complying with the provisions of this Section 3.4, comply with the other provisions of this Article
III. 
 (c) Within thirty (30) days after delivery of the Co-Sale Notice, each Other Stockholder may elect to participate in the
proposed Transfer by delivering to such Co-Sale Transferor a notice (the “Tag-Along Notice”) specifying the number of Equity Securities (up to his, her or its Pro Rata Amount (based upon the aggregate number of Equity Securities of
the Corporation outstanding at such time) with respect to which such Other Stockholder shall exercise his, her or its rights under this Section 3.4. Each Tag-Along Notice may include any Common Stock Equivalents owned by the Other Stockholders.
For purposes of this Section 3.4, each Other Stockholder may aggregate his, her or its Pro Rata Amount among Other Stockholders in his, her or its Group to the extent that such Other Stockholders in his, hers or its Group do not elect to sell
their respective Pro Rata Amounts. 
  

 18 

 (d) Any Equity Securities requested to be included in any Co-Sale Notice shall be Transferred on at least
the same terms and conditions as are set forth in the Co-Sale Notice, provided, however, that the price for each Common Stock Equivalent shall be (i) the product of (x) the price per share of Common Stock Transferred or to be
Transferred by the Co-Sale Transferor and (y) the number of shares of Common Stock into which such Common Stock Equivalent is then convertible in accordance with the Charter. 
 (e) If the Transfer contemplated by the Co-Sale Notice is not completed with the Co-Sale Transferee within seventy-five (75) days following the
receipt of the Co-Sale Notice by the Other Stockholders (unless the reason it is not completed relates to the Co-Sale Transferee’s breach of its agreement to purchase such Shares), then the Shares that are the subject of the Co-Sale Notice
shall continue to be subject to all of the terms of this Agreement as if no Co-Sale Notice had been given. 
 (f) Transfers pursuant to this
Section 3.4 shall be made at the offices of the Corporation on a mutually satisfactory Business Day within the applicable period described above. Delivery of stock certificates or other instruments evidencing such Transferred Shares duly
endorsed for Transfer to the Co-Sale Transferee shall be made on such date against payment of the purchase price thereof. 
  

	3.5.	Preemptive Rights. 

 (a) If the Corporation
proposes to issue any New Securities to any Person, the Corporation shall, before such issuance, deliver to the Stockholders (other than those Stockholders that are not “accredited investors” (as such term is defined in Rule 501 of the
Securities Act)) (collectively, the “Subscribing Stockholders”) a written notice offering to issue to the Subscribing Stockholders such New Securities upon the terms set forth in this Section 3.5 (the “Preemptive Offer
Notice”). The Preemptive Offer Notice shall state that the Corporation proposes to issue New Securities and shall set forth the number and terms and conditions (including the purchase price and the proposed purchasers) of such New
Securities. The offer (the “Preemptive Offer”) shall remain open and irrevocable for a period of ten (10) Business Days (the “Preemptive Offer Period”) from the date of its delivery. 
 (b) Each Subscribing Stockholder may accept the Preemptive Offer by delivering to the Corporation a notice (the “Purchase Notice”) at
any time during the Preemptive Offer Period. The Purchase Notice shall state the number (the “Preemptive Offer Number”) of New Securities such Subscribing Stockholder desires to purchase. If the sum of all Preemptive Offer Numbers
exceeds the number of New Securities, the New Securities shall be allocated among the Subscribing Stockholders that delivered a Purchase Notice in accordance with their respective Pro Rata Amount (based on the aggregate number of Common Stock
Equivalents outstanding at the time of the Preemptive Offer and held by all Subscribing Stockholders). 
 (c) The issuance of New Securities
to the Subscribing Stockholders who delivered a Purchase Notice shall be made on a Business Day, as designated by the Corporation, 

  

 19 

 
not less than ten (10) and not more than sixty (60) days after expiration of the Preemptive Offer Period on those terms and conditions of the
Preemptive Offer not inconsistent with this Section 3.5. 
 (d) If the number of New Securities exceeds the sum of all Preemptive Offer
Numbers, the Corporation may issue such excess or any portion thereof on the terms and conditions set forth in the Preemptive Offer to any Person within ninety (90) days after expiration of the Preemptive Offer Period. If such issuance is not
made within such 90-day period, the restrictions provided for in this Section 3.5 shall again become effective. 
 (e) For purposes of
this Section 3.5 each Subscribing Stockholder may aggregate his, her or its Pro Rata Amount among other Subscribing Stockholders in his, her or its Group to the extent that other Subscribing Stockholders in his, her or its Group do not elect to
purchase their respective Pro Rata Amounts. 
 (f) Notwithstanding anything to the contrary contained herein, the Corporation may, in order
to expedite the issuance of the New Securities under this Section 3.5, issue all or a portion of the New Securities to one or more Persons (each, an “Initial Subscribing Investor”), without complying with the provisions of this
Section 3.5; provided, that prior to such issuance, either (i) each Initial Subscribing Investor agrees to offer to sell to each Stockholder who is an accredited investor (as such term is defined in Rule 501 under the Securities
Act) and who is not an Initial Subscribing Investor (each such Stockholder, an “Other Accredited Stockholder”) his or its respective Pro Rata Amount of such New Securities on the same terms and conditions as issued to the Initial
Subscribing Investors or (ii) the Corporation shall offer to sell an additional amount of New Securities to each Other Accredited Stockholder only in an amount and manner which provides such Other Accredited Stockholders with rights
substantially similar to the rights outlined in Sections 3.5(b) and 3.5(c). The Initial Subscribing Investors or the Corporation, as applicable, shall offer to sell such New Securities to each Other Accredited Stockholder within sixty (60) days
after the closing of the purchase of the New Securities by the Initial Subscribing Investors. 
 (g) The provisions of this Section 3.5
may be waived in writing with respect to an issuance of New Securities by a Majority in Interest of the Investors, provided, that none of the Investors acquire any New Securities in connection with such issuance. 
  

	3.6.	Right of First Refusal. 

 (a) If any
Management Stockholder receives an offer to purchase all or any portion of his or its Management Stockholder Shares (or any Equity Securities issued in respect thereof) (the recipient of such an offer, the
“Seller” and the Equity Securities subject to such offer, the “Refusal Shares”), from an unrelated bona fide third party purchaser and the Seller desires to
accept such offer, the Seller shall set forth the terms of the offer, including, without limitation, the number of Equity Securities to which such offer relates, the proposed amount and type of consideration and the identity and address of the
proposed third party purchaser in a notification (the “Offer Notice”) and deliver such offer to the Corporation and the Investors (the “Offerees”). 

 

 20 

 (b) For a period of twenty (20) days from the date of receipt of the Offer Notice, the Corporation
shall have the option, exercisable by providing notification to the Seller, to purchase all or a portion of the Refusal Shares on substantially the same terms and conditions as are set forth in the Offer Notice. 
 (c) If the Corporation fails to elect to purchase all of the Refusal Shares within such twenty (20) day period, or if the Corporation elects to
purchase some but not all of the Refusal Shares, then the Investors and the Management Stockholders (other than the Seller) shall have a second option, in accordance with their Pro Rata Amounts, exercisable by providing notification to the Seller
within thirty (30) days from the date of receipt of the Offer Notice, to purchase any and all of the remaining Refusal Shares. 
 (d)
For purposes of this Section 3.6, each Investor and Management Stockholder (other than the Seller) may aggregate his, her or its Pro Rata Amount among other Investors or Management Stockholders, as applicable, in his, her or its Group to the
extent that other Investors or Management Stockholders, as applicable, in his, her or its Group do not elect to purchase their respective Pro Rata Amounts. 
 (e) If the Corporation, the Investors and the Management Stockholders, either individually or in the aggregate, elect to purchase all (but not less than all) of the Refusal Shares, then the Corporation, the Investors
and the Management Stockholders, as the case may be, shall be obligated to purchase, and the Seller shall be obligated to sell, the Refusal Shares at the price and on the other terms and conditions set forth in the Offer Notice. 
 (f) If the Corporation, the Investors and the Management Stockholders shall not have elected to purchase, in the aggregate, all of the Refusal Shares, or
if the sale to the Corporation, the Investors and the Management Stockholders is not completed within seventy-five (75) days following receipt of the Offer Notice (unless the reason it is not completed relates to the Seller’s breach of its
agreement to sell), the Seller shall be free to sell all (but not less than all) of the Refusal Shares to the third party purchaser identified in the Offer Notice at the price and on the other terms and conditions contained in the Offer Notice
within seventy-five (75) days after the expiration of all election periods provided for in this Section 3.6, but not to any other purchaser, or at any other price or upon any other terms and conditions materially different than those
contained in the Offer Notice. However, if the Seller has not completed the sale of all of the Refusal Shares within such seventy-five (75) day period in accordance with the above conditions, then the Refusal Shares shall continue to be subject
to all of the terms of this Agreement as if no Offer Notice had been given. 
 (g) Transfers pursuant to this Section 3.6 shall be made
at the offices of the Corporation on a mutually satisfactory Business Day within the applicable period described above. Delivery of stock certificates or other instruments evidencing such Refusal Shares duly endorsed for Transfer shall be made on
such date against payment of the purchase price thereof. 
 (h) The provisions of this Section 3.6 shall not apply with respect to
(i) Permitted Transfers, or (ii) Transfers pursuant to Sections 3.3, 3.4, 3.5(f) or 3.7. 
  

 21 

	3.7.	Approved Sale; Sale of the Corporation. 

 (a)
At any time that a Majority in Interest of the Investors shall approve a Sale of the Corporation to one or more Persons (an “Approved Sale”), each Stockholder and the Corporation shall consent to and raise no objections against the
Approved Sale, and if the Approved Sale is structured as (A) a merger or consolidation of the Corporation, each Stockholder shall, and hereby does, waive any dissenter’s rights, appraisal rights or similar rights in connection with such
merger or consolidation and hereby instructs the Board to vote in favor of such Approved Sale, or (B) a sale of shares of capital stock, each Stockholder shall, and hereby does, agree to sell their Equity Securities on the terms and subject to
the conditions approved by such Investors. All Stockholders and the Corporation shall take all necessary and desirable actions in connection with the consummation of the Approved Sale, including, without limitation, the execution of such agreements
and such instruments and other actions reasonably necessary to (1) provide the customary representations, warranties, indemnities, covenants, conditions, escrow agreements and other provisions and agreements relating to such Approved Sale and
(2) to effectuate the allocation and distribution of the aggregate consideration upon the Approved Sale as set forth below. The Stockholders shall not be required to comply with, and shall have no rights under, Section 3.1 through 3.6 in
connection with any Approved Sale. 
 (b) The Corporation shall provide the Stockholders with written notice of any Approved Sale at least
ten (10) days prior to the consummation thereof setting forth in reasonable detail the terms (including price, time and form of payment) of any Approved Sale. The obligations of the Stockholders to participate in any Approved Sale are subject
to the satisfaction of the following conditions: 
 (i) each Stockholder shall receive the same portion of the aggregate
consideration from such Approved Sale that such Stockholder would have received if such aggregate consideration (in the case of an asset sale, after payment or provision for all liabilities) had been distributed by the Corporation in a Liquidation;

 (ii) if any Stockholders of a class, series or type of Equity Securities are given an option as to the form and amount of
consideration to be received with respect to Equity Securities in a class, series or type, all holders of Equity Securities of such class, series or type will be given the same option; and 
 (iii) no Stockholder shall be obligated to pay more than his or its Pro Rata Amount of any indemnity payments, escrow amounts or
reasonable expenses incurred (based on the proportion of the aggregate transaction consideration received) in connection with a consummated Approved Sale to the extent such expenses are incurred for the benefit of all Stockholders and are not
otherwise paid by the Corporation or the acquiring party (expenses incurred by or on behalf of a Stockholder for its or his sole benefit not being considered expenses incurred for the benefit of all Stockholders). 
 (c) Each Stockholder and the Corporation hereby grants an irrevocable proxy and power of attorney to any nominee of a Majority in Interest of the
Investors (which may be an Investor) (the “Investor Nominee”) to take all necessary actions and execute and deliver all documents deemed necessary and appropriate by such Person to effectuate the consummation of 

  

 22 

 
any Approved Sale. The Stockholders hereby agree to indemnify, defend and hold the Investor Nominee harmless (severally in accordance with their pro rata
share of the consideration received in any such Approved Sale (and not jointly and severally)) against all liability, loss or damage, together with all reasonable costs and expenses (including reasonable legal fees and expenses), relating to or
arising from its exercise of the proxy and power of attorney granted hereby. 
 (d) In addition to the obligations of the Corporation and the
Stockholders set forth in this Section 3.7, if the Corporation has not consummated a Sale of the Corporation or a QIPO on or before the fifth anniversary of the date of this Agreement, then, at any time after such date at the request of a
Majority in Interest of the Investors, the Corporation shall retain a nationally recognized investment bank (which shall be reasonably acceptable to a Majority in Interest of the Investors) for the purpose of effecting a Sale of the Corporation. The
Corporation shall cause each of its officers to participate actively in the sale process (including assisting with the preparation of an offering memorandum and being available to meet with representatives of prospective purchasers) as requested by
such investment bank and the Board. The Corporation shall permit the Investor Nominee to represent the Corporation in such sale process. The Corporation and the Stockholders shall expeditiously effect a Sale of the Corporation on terms reasonably
satisfactory to a Majority in Interest of the Investors. In connection therewith, the Corporation and Stockholders shall comply with all of their obligations set forth in Sections 3.7(a) through 3.7(c) with respect to such Sale of the Corporation
and shall indemnify the Investor Nominee with respect to its appointment under this Section 3.7(d) in the manner specified in Section 3.7(c).  
 ARTICLE IV 
 PROTECTIVE PROVISIONS 
  

	4.1.	Investor Director Protective Covenants. 

 The
Corporation shall not take any of the following actions without the prior written approval of at least one (1) Investor Director: 
 (a)
(A) issue or authorize any options (other than options not to exceed 83,272 issued pursuant to the Corporation’s Stock Incentive Plan), (B) issue any stock appreciation or similar rights, (C) create a bonus plan or program or issue
any bonuses or agree to issue bonuses, the payment of which is contingent upon the occurrence of a Liquidation, change of control or similar event, (D) redeem, repurchase or acquire any Equity Securities, or (E) re-price any stock options;

 (b) issue debt for borrowed money (other than debt issued to a Subsidiary); 
 (c) pledge any assets (other than in connection with capital leases or other financings that have been previously approved by a Majority in Interest of
the Investors); 
 (d) make any changes in accounting methods or policies (other than as required by U.S. generally accepted accounting
principles), or any change in the Corporation’s auditors; 
  

 23 

 (e) effect any sales or other dispositions of assets exceeding $100,000; 
 (f) adopt an annual budget, operating budget or business plan; 
 (g) effect any changes in the strategic direction or lines of business of the Corporation not specified in the business plan approved by the Board; 
 (h) change the name under which the Corporation conducts business; 
 (i) create any Subsidiary; 
 (j) create any committee of the Board or permit any such committee to take any
action; 
 (k) make investments in any other Person (other than a Subsidiary); 
 (l) commence or terminate the employment of the chief executive officer, president, chief financial officer, chief operating officer or any other senior
executive officer of the Corporation, or amend or revise the terms of any employment agreement with any such officer; 
 (m) enter into any
contract or agreement with any officer, director, stockholder, Affiliate or employee (each a “Related Person”) of the Corporation or any Subsidiary, including, without limitation, for the sale or repurchase of any of the
Corporation’s Equity Securities (other than (A) repurchase rights existing on or prior to the date of this Agreement (B) the Management Agreement or (C) any contract or agreement entered into with such Related Person on terms not
less favorable to the Corporation or Subsidiary, as the case may be, than would be obtained in a transaction with a Person which is not a Related Person); 
 (n) grant any exclusive rights to any intellectual property of the Corporation; 
 (o) change or otherwise
modify in any way the compensation of any employee with an aggregate annual compensation package equal to or greater than $150,000 (inclusive of any annual bonus that may be payable to such employee); 
 (p) enter into any contract, commitment or arrangement (other than the Management Agreement) with respect to the receipt by the Corporation (or any
Subsidiary thereof) of either (i) investment banking services with respect to material issuances of securities or (ii) advisory services with respect to mergers and acquisitions involving the Corporation (or any Subsidiary thereof);

 (q) settle any workers’ compensation claims or any material lawsuit, arbitration, proceeding or investigation related thereto, other
than those workers’ compensation claims, material lawsuits, arbitrations, proceedings or investigations for which the Investors have received written notification that the Sellers (as defined in the Purchase Agreement) are obligated to fully
indemnify, defend and hold harmless the Investors or the Corporation for any and all losses in connection therewith under the terms of the Purchase Agreement; or 
  

 24 

 (r) agree to take any of the foregoing actions. 
  

	4.2.	Investor Stockholders Protective Covenants. 

 The Corporation shall not take any of the following actions without the prior written approval of a Majority in Interest of the Investors: 
 (a) effect any changes in the strategic direction or lines of business of the Corporation not specified in the business plan approved by the Board; 
 (b) issue or authorize any Equity Securities (other than options issued pursuant to the Corporation’s Stock Incentive Plan) ; 
 (c) effect any acquisition by the Corporation of any business (whether by purchase of stock or assets) or any expenditures in excess of $50,000 not included in the annual operating budget; 
 (d) take any action that could result in a Liquidation; 
 (e) in any manner alter or change the terms, designations, powers, preferences or relative, participating, optional or other special rights, or the qualifications, limitations or restrictions, of the Series A
Preferred Stock; 
 (f) effect any changes in the Charter or Bylaws; 
 (g) except as otherwise contemplated in this Agreement, alter the size of the Board or any committee thereof; 
 (h) in any manner, directly or indirectly, and whether in cash, securities, dividends or other property, pay or declare or set apart for payment, any
dividends (other than dividends at the Series A Dividend Rate (as defined in the Charter) with respect to the shares of Series A Preferred Stock or make any other distribution on or with respect to any Equity Securities; 
 (i) initiate a process with respect to, or consummate, a Public Offering; or 
 (j) agree to take any of the foregoing actions. 
  

	4.3.	Management Stockholders Protective Covenants. 

 For so long as the Management Stockholders continue to own, directly or indirectly, at least twenty-five percent (25%) of the Management Stockholder Shares owned by them in the aggregate on the date hereof, the Corporation shall not
take any of the following actions without the prior written approval of a Majority in Interest of the Management Stockholders: 
 (a) effect
any changes in the strategic direction or lines of business of the Corporation not specified in the business plan approved by the Board; 
  

 25 

 (b) create any Subsidiary not, directly or indirectly, wholly-owned by the Corporation, or issue any
Equity Securities or rights to acquire Equity Securities in any Subsidiary (other than to the Corporation or a wholly-owned Subsidiary of the Corporation); 
 (c) create any committee of the Board; 
 (d) enter into any contract or agreement with any Related Person of
the Corporation or any Subsidiary, including, without limitation, for the sale or repurchase of any of the Corporation’s Equity Securities (other than (i) repurchase rights existing on or prior to the date of this Agreement, (ii) the
Management Agreement or (iii) any contract or agreement entered into with such Related Person on terms materially not less favorable to the Corporation or a Subsidiary, as the case may be, than would be obtained in a transaction with a Person
which is not a Related Person); 
 (e) in any manner alter or change the terms, designations, powers, preferences or relative, participating,
optional or other special rights, or the qualifications, limitations or restrictions, of the Series A Preferred Stock; 
 (f) except as
otherwise contemplated in this Agreement, alter the size of the Board or any committee thereof; 
 (g) effect any changes in the Charter or
Bylaws to the extent that such change would have a disproportionate impact on the rights of the Management Stockholders; or 
 (h) agree to
take any of the foregoing actions. 
  

	4.4.	Subsidiaries and Committees. 

 At any time
that the Corporation has any Subsidiary or committee, it shall not permit such Subsidiary or committee, as the case may be, to take any of the foregoing actions set forth in Sections 4.1, 4.2 or 4.3 (with all references to the Corporation deemed to
be references to such Subsidiary or committee) without the prior written approval of an Investor Director, a Majority in Interest of the Investors, or a Majority in Interest of the Management Stockholders, as the case may be. 
 ARTICLE V 
 ADDITIONAL AGREEMENTS

  

	5.1.	Information Rights. 

 (a) The Corporation
shall deliver the following reports to each Investor and each Major Management Stockholder: 
 (i) as soon as available and in
any event within thirty (30) days after the end of each month of each fiscal year of the Corporation, consolidated and consolidating balance sheets of the Corporation and its Subsidiaries as of the end of such period, and consolidated and
consolidating statements of income and cash flows of the 

  

 26 

 
Corporation and its Subsidiaries for the period then ended, including a report containing a management’s discussion and analysis of such financial
results prepared in conformity with GAAP, except as otherwise noted therein, and subject to the absence of footnotes and to year-end adjustments; 
 (ii) as soon as available and in any event within forty-five (45) days after the end of each of the first three quarters of each fiscal year of the Corporation, consolidated and consolidating balance sheets of
the Corporation and its Subsidiaries as of the end of such period, and consolidated and consolidating statements of income and cash flows of the Corporation and its Subsidiaries for the period then ended prepared in conformity with GAAP, except as
otherwise noted therein, and subject to the absence of footnotes and to year-end adjustments; 
 (iii) as soon as available
and in any event within ninety (90) days after the end of each fiscal year of the Corporation, a consolidated and consolidating balance sheet of the Corporation and its Subsidiaries as of the end of such year, and consolidated and consolidating
statements of income and cash flows of the Corporation and its Subsidiaries for the year then ended prepared in conformity with GAAP, except as otherwise noted therein, together with an auditor’s report thereon of a public accounting firm of
established national reputation; 
 (iv) to the extent the Corporation (or any Subsidiary thereof) is required to prepare such
financial statements (or obtain such audit letters), any financial statements actually prepared by the Corporation (or any such Subsidiary), or audit letters actually obtained by the Corporation (or any such Subsidiary) from any auditor of such
financial statements, in each case as soon as available to the Corporation (or such Subsidiary); and 
 (v) to the extent the
Corporation (or any Subsidiary thereof) is required by law to prepare such reports, any annual reports, quarterly reports and other periodic reports pursuant to Section 13 or 15(d) of the Exchange Act actually prepared by the Corporation (or
any Subsidiary thereof) as soon as available. 
 (b) The Corporation and its Subsidiaries shall provide to each Investor and each Major
Management Stockholder, true and correct copies of all documents, reports, financial data and other information as an Investor or Major Management Stockholder may reasonably request. The Corporation shall permit any authorized representatives
designated by an Investor or Major Management Stockholder to visit and inspect any of the properties of the Corporation and its Subsidiaries, including its and their books of account, and to discuss its and their affairs, finances and accounts with
its and their officers, all at such times as an Investor or Major Management Stockholder may reasonably request. 
 (c) The Corporation will
give each Investor and each Major Management Stockholder reasonable prior notice (it being agreed that substantially the same prior notice given to the members of the Board shall be deemed reasonable prior notice) of the time and place of any
proposed meeting of the Board. The Corporation will deliver to each Investor and each Major Management Stockholder copies of all material documentation distributed from time to 

  

 27 

 
time to the members of the Board or any applicable committee thereof, at such time as such documents are so distributed to them, including copies of any
written consent. The Corporation reserves the right to withhold any such documentation if (i) access to such documentation could be reasonably expected to adversely affect the attorney-client privilege between the Corporation and its counsel or
(ii) such disclosure is prohibited by an agreement with a third party; provided, however, that in the case of the preceding clause (ii), the Corporation will use commercially reasonable efforts to provide such documentation, which
requirement shall be satisfied if the Investor or Major Management Stockholder is offered the opportunity to obtain such documentation by executing or otherwise becoming a party to the confidentiality restrictions on substantially the same terms
(including any standstill provisions) as are applicable to the Corporation. Notwithstanding anything to the contrary contained in this Agreement, an Investor or Major Management Stockholder may not use or disclose any information received by such
Investor or Major Management Stockholder, unless and except to the extent that such use or disclosure could have been made by a director of the Corporation in compliance with all laws and duties applicable to a director as such under such
circumstances. 
  

	5.2.	Access to Records and Properties. 

 The
Corporation shall permit any Investor and its employees, counsel and other authorized representatives, and any Major Management Stockholder (collectively, “Authorized Representatives”) during normal business hours and upon
reasonable advance notice (which shall not be less than one-day’s prior notice) to (a) visit and inspect the assets and properties of the Corporation and its Subsidiaries, (b) examine the books of accounts and records of the
Corporation and its Subsidiaries, (c) make copies of such records and (d) discuss all aspects of the Corporation and its Subsidiaries with any officers, employees or accountants of the Corporation and its Subsidiaries; provided,
however, that such investigation shall not unreasonably interfere with the operations of the Corporation and its Subsidiaries. The Corporation will instruct the accountants of the Corporation and its Subsidiaries to discuss such aspects of
the financial condition of the Corporation and its Subsidiaries with any such Investor or Major Management Stockholder and its Authorized Representatives as such Investor or Major Management Stockholder may reasonably request, and to permit such
Investor, Major Management Stockholder and their Authorized Representatives to inspect, copy and make extracts from such financial statements, analyses, and other documents and information (including electronically stored documents and information)
prepared by the accountants with respect to the Corporation and its Subsidiaries as such Investor or Major Management Stockholder may reasonably request. All costs and expenses incurred by such Investor, Major Management Stockholder and their
Authorized Representatives in connection with exercising such rights of access shall be borne by such Persons, and all out-of-pocket costs and expenses incurred by the Corporation and its Subsidiaries in complying with any extraordinary requests by
such Persons and its representatives in connection with exercising such access rights shall be borne by such Persons. 
  

	5.3.	Regulatory Matters. 

 Each Stockholder agrees
to cooperate with the Corporation in all reasonable respects in complying with the terms and provisions of the Regulatory Agreement regarding regulatory matters. Anything contained in this Section 5.3 to the contrary notwithstanding, no
Stockholder shall be required under this Section 5.3 to take any action that would adversely affect in any material respect such Stockholder’s rights under this Agreement or as a Stockholder. 
  

 28 

	5.4.	Expenses. 

 The Corporation will pay, and
hold the Investors and the Management Stockholders, as the case may be, and/or their respective representatives harmless against all liability for the payment of, (i) all costs and other expenses incurred from time to time by the Corporation or
any of its Subsidiaries in connection with the Corporation’s or any of its Subsidiaries’ performance of and compliance with all agreements and conditions contained in this Agreement on its part to be performed or complied with,
(ii) the out-of-pocket costs and expenses incurred by the Investors and any of their Affiliates at or prior to the consummation of the transactions contemplated by this Agreement, including fees and charges of counsel, accountants and other
advisors, in connection with the purchase of the securities contemplated by the Purchase Agreement or any securities directly or indirectly issuable upon the conversion, exercise or exchange of such securities, (iii) the reasonable costs and
expenses (including fees and expenses of counsel, accountants and other advisors) incurred by the Stockholders and their respective Affiliates in connection with any amendment or waiver of, or enforcement of, any of the provisions of this Agreement;
provided, however, that none of the Stockholders shall be entitled to reimbursement for any costs incurred in connection with a dispute hereunder, (iv) any out-of-pocket costs incurred by the Stockholders or their Affiliates in
rendering assistance to the Corporation or any of its Subsidiaries, to the extent the Corporation or such Subsidiary requested such assistance (it being understood that, except as set forth in the Management Agreement, the Investors and their
Affiliates shall not be obligated to render, and may charge additional fees for, such assistance), (v) the fees and expenses incurred by the Investors and their Affiliates in any filing with any Governmental Entity with respect to its
investment in the Corporation or in any other filing with any Governmental Entity with respect to the Corporation or any of its Subsidiaries that mentions the Investors or any of their Affiliates, and (vi) any stamp or similar taxes which may
be determined to be payable in connection with the execution and delivery and performance of the Purchase Agreement and any of the transactions contemplated thereby, or any modification, amendment or alteration of the Purchase Agreement, and all
issue taxes in respect of the issuance of any securities of the Corporation; provided, however, that it is understood by the parties hereto that the Management Stockholders shall not be entitled to reimbursement for any costs and
expenses, or indemnified for any liability, arising from, in connection with or related to the preparation for and consummation of the transactions contemplated by the Purchase Agreement. 
  

	5.5.	Irrevocable Proxy. 

 Except as set forth in
Section 2.2(c) and 3.7(c) hereof, James A. Wright and Courtney E. Panzer hereby deliver to W. Andrew Wright, III an irrevocable proxy, coupled with an interest, authorizing W. Andrew Wright, III to act as proxy of such Management Stockholder,
with full powers of substitution and resubstitution, and hereby authorize W. Andrew Wright, III to vote, give consents and in all other ways act in such Management Stockholder’s place with respect to all Management Stockholder Shares held by
such Management Stockholder (and any and all other Equity Securities issued in respect thereof) in connection with such Management Stockholder’s agreements contained in this Agreement (other than Section 2.2(c) and 3.7(c) hereof), which
proxy shall be valid and remain in effect throughout the term of this Agreement. 
  

 29 

	5.6.	Director’s and Officer’s Insurance. 

 The Company and each Subsidiary shall maintain, or shall cause to be maintained, director’s and officer’s liability insurance with responsible and reputable insurance companies or associations in such amounts and covering such
risks as are customarily carried by companies engaged in similar businesses and owning similar properties in the same general areas in which the Company or such Subsidiary operates and on commercially reasonable terms. 
 ARTICLE VI 
 MISCELLANEOUS

  

	6.1.	Termination. 

 This Agreement shall
automatically terminate and be of no further force or effect as of the Termination Date. 
  

	6.2.	Legend on Stock Certificates. 

 Each
certificate representing shares of capital stock that are subject to this Agreement shall bear a legend substantially in the following form: 
 “THE SALE, TRANSFER, ASSIGNMENT, PLEDGE, OR ENCUMBRANCE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE AND THE RIGHTS OF THE HOLDER OF SUCH SECURITIES IN RESPECT OF THE ELECTION OF DIRECTORS ARE SUBJECT TO A STOCKHOLDERS’
AGREEMENT DATED AS OF SEPTEMBER 19, 2006 (AS IT MAY BE AMENDED, RESTATED OR OTHERWISE MODIFIED FROM TIME-TO-TIME), AMONG ADDUS HOLDING CORPORATION AND CERTAIN HOLDERS OF ITS OUTSTANDING CAPITAL STOCK. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT
NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF ADDUS HOLDING CORPORATION.” 
  

	6.3.	Governing Law; Dispute Resolution. 

 (a)
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any law or rule that would cause the laws of any jurisdiction other than the State of Delaware to
be applied. 
 (b) Dispute Resolution. 
 (i) Any controversy or claim arising out of or relating to this Agreement (including, without limitation, as to arbitrability), or the breach thereof, shall be settled by individual arbitration (as opposed to class or
collective arbitration) administered by a 

  

 30 

 
Person (the “Arbitrator”) mutually selected by the parties to any such dispute. If the parties are unable to agree upon the Arbitrator, they
shall each select an arbitrator and the selected arbitrators shall appoint a separate arbitrator to act as the Arbitrator. For purposes of this Section 6.3(b), (x) if the dispute involves the Investors as a group, a Majority in Interest of
the Investors shall act on behalf of the Investors as a group, (y) if the dispute involves the Management Stockholders as a group, a Majority in Interest of the Management Stockholders shall act on behalf of the Management Stockholders as a
group, and (z) if the dispute involves the Company, the board of directors of the Company or a duly authorized officer shall act on behalf of the Company. 
 (ii) In the event of any dispute, claim, question or disagreement arising from or relating to this Agreement, or the breach hereof or thereof, the parties shall use their commercially reasonable efforts to resolve the
dispute, claim, question or disagreement. To this effect, each party to the dispute shall appoint a representative (a “Representative”) and the appointed Representatives will meet in person or by telephone within ten
(10) Business Days of any party’s receipt of a written notice informing that party of the existence of a dispute, claim, question or disagreement. If the Representatives do not resolve or settle the matter within ten (10) Business
Days after the initial meeting, or following any longer period as the parties may agree to in writing, the Representatives shall then immediately submit the dispute to binding arbitration in accordance with this Section 6.3(b). 
 (iii) The arbitration hearing shall commence within ninety (90) calendar days after the Arbitrator is selected, unless the Representatives agree to
extend this time period. The arbitration shall take place in New York, New York. 
 (iv) The arbitration shall be conducted pursuant to the
Federal Rules of Procedure and the Federal Rules of Evidence. The Arbitrator will have full power to give directions and make such orders as the Arbitrator deems just. Nonetheless, the Arbitrator explicitly shall not have the authority, power, or
right to alter, change, amend, modify, add, or subtract from any provision of this Agreement. 
 (v) The Arbitrator shall issue a written
decision within thirty (30) days after the conclusion of the arbitration hearing, which decision shall be rendered without reference to the reason for the arbitrator’s decision or any citation to precedent. The agreement to arbitrate will
be specifically enforceable. The award rendered by the arbitrator shall be final and binding (absent fraud or manifest error), and any arbitration award may be enforced by judgment entered in any court of competent jurisdiction. The fees and
expenses of the arbitrator shall be allocated between the parties to the dispute in the same proportion that the aggregate amount of the disputed items submitted to the Arbitrator that is unsuccessfully disputed by each such party (as finally
determined by the Arbitrator) bears to the total amount of such disputed items so submitted. 
 (vi) During any arbitration proceeding, the
parties shall continue to perform their respective obligations under this Agreement. 
  

 31 

	6.4.	Severability. 

 It is the desire and intent
of the parties that the provisions of this Agreement be enforced to the fullest extent permissible under the law and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, in the event that any provision of this
Agreement would be held in any jurisdiction to be invalid, prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the
validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such
jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. 
  

	6.5.	Assignments; Successors and Assigns. 

 Except
in connection with any Transfer of Shares in accordance with this Agreement, the rights of each party under this Agreement may not be assigned. This Agreement shall bind and inure to the benefit of the parties and their respective successors,
permitted assigns, legal representatives and heirs. 
  

	6.6.	Amendments; Waivers. 

 The terms and
provisions of this Agreement may not be modified or amended except pursuant to a writing signed by the Corporation and Stockholders holding at least a majority of all outstanding Equity Securities; provided, however, any such
modification or amendment that would have a disproportionate impact on the rights of (i) the Management Stockholders shall not be effective without the prior written consent of a Majority in Interest of the Management Stockholders and
(ii) Freeport shall not be effective without the prior written consent of Freeport. Any waiver of any provision of this Agreement requested by any party hereto must be granted in advance, in writing by the party granting such waiver;
provided, however, that a Majority in Interest of the Investors may grant a waiver on behalf of all Investors and a Majority in Interest of the Management Stockholders may grant a waiver or effect a modification or amendment on behalf
of all Management Stockholders. 
  

	6.7.	Notices. 

 All notices, requests, consents
and other communications hereunder to any party shall be deemed to be sufficient if contained in a written instrument delivered in person or sent by telecopy, nationally-recognized overnight courier or first class registered or certified mail,
return receipt requested, postage prepaid, addressed to such party at the address set forth below or such other address as may hereafter be designated in writing by such party to the other parties: 
 if to the Corporation: 
 Addus Holding
Corporation 
 c/o Eos Management, Inc. 
 320 Park Avenue 
 New York, New York 10022 
  

 32 

 Attention: Mark L. First 
 Telephone: (212) 832-5800 
 Facsimile: (212) 832-5815 
 with a copy (which shall not constitute notice) to: 
 King & Spalding, LLP 
 1185 Avenue of the Americas 
 New York, New York 10036 
 Attention: Dominick
P. DeChiara, Esq. 
 Telephone: (212) 827-4098 
 Facsimile: (212) 556-2222; 
 if to the Stockholders, to their respective addresses set forth on Annex I and II hereto.

 All such notices, requests, consents and other communications shall be deemed to have been delivered (a) in the case of personal
delivery or delivery by telecopy, on the date of such delivery, (b) in the case of dispatch by nationally-recognized overnight courier, on the next Business Day following such dispatch and (c) in the case of mailing, on the third Business
Day after the posting thereof. 
  

	6.8.	Headings. 

 The headings of the sections of
this Agreement have been inserted for convenience of reference only and shall not be deemed to be a part of this Agreement. 
  

	6.9.	Nouns and Pronouns. 

 Whenever the context
may require, any pronouns used herein shall include the corresponding masculine, feminine or neuter forms, and the singular form of names and pronouns shall include the plural and vice versa. 
  

	6.10.	Entire Agreement. 

 This Agreement contains
the entire agreement among the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings with respect to such subject matter. The parties hereto represent and warrant that there are no other agreements
or understandings regarding any of the subject matter hereof other than as set forth herein and covenant not to enter into any such agreements or understandings after the date hereof except pursuant to an amendment, modification or waiver of the
provisions of this Agreement. 
  

	6.11.	Counterparts. 

 This Agreement may be
executed in any number of original or facsimile counterparts, and each such counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement. 
  

 33 

	6.12.	Conflicting Agreements. 

 No Stockholder
shall enter into any stockholder agreements or arrangements of any kind with any Person with respect to any Equity Securities on terms inconsistent with the provisions of this Agreement (whether or not such agreements or arrangements are with other
Stockholders or with Persons that are not parties to this Agreement), including agreements or arrangements with respect to the acquisition or disposition of Equity Securities in a manner which is inconsistent with this Agreement, but excluding the
transaction documents contemplated by the Purchase Agreement. 
  

	6.13.	Third Party Reliance. 

 Notwithstanding
anything contained herein to the contrary, the covenants of the Corporation contained in this Agreement (a) are being given by the Corporation as an inducement to the Stockholders to enter into this Agreement (and the Corporation acknowledges
that the Stockholders have expressly relied thereon) and (b) are solely for the benefit of the Stockholders. Accordingly, no third party (including, without limitation, any holder of capital stock of the Corporation) or anyone acting on behalf
of anyone thereof other than the Stockholders, shall be a third party or other beneficiary of such covenants and no such third party shall have any rights of contribution against the Stockholders or the Corporation with respect to such covenants or
any matter subject to or resulting in indemnification under this Agreement or otherwise. 
  

	6.14.	Consultation with Counsel, etc. 

 Each
Stockholder who or which executes and delivers a counterpart signature page to this Agreement hereby acknowledges that he, she or it has had the opportunity to consult with his, her or its own counsel with respect to the subject matter of this
Agreement, and has read and understands all of the provisions of this Agreement. Each Stockholder who or which executes and delivers a counterpart signature page to this Agreement hereby further acknowledges that he, she or it has had the
opportunity to ask questions of, and to seek additional information from, the Corporation with respect to each of the matters set forth herein. 
  

	6.15.	Prevailing Party. 

 Subject to
Section 6.3(b), if any party to this Agreement brings an action or proceeding directly or indirectly based upon this Agreement or the matters contemplated hereby against any other party hereto (or its Afiliates), the Prevailing Party shall be
entitled to recover, in addition to any other appropriate amounts, its reasonable fees, costs and expenses in connection with such action or proceeding, including, but not limited to, reasonable attorneys’ fees, fees of expert witnesses and
expenses and court costs. In any action seeking monetary damages, (A) the party bringing such action must expressly state a claimed dollar amount in its complaint or as a counterclaim in its answer and (B) the parties agree that they may
not amend their respective complaint or answer to change the dollar amount of damages originally sought. 
  

 34 

	6.16.	Interpretation. 

 Notwithstanding anything to
the contrary contained herein or in the Bylaws, to the extent that any provision contained in this Agreement conflicts with any provision contained in the Bylaws, the provision contained in this Agreement shall govern. 
  

	6.17.	Lender. 

 Notwithstanding anything herein to
the contrary, nothing contained in this Agreement shall affect, limit or impair the rights and remedies of Freeport, any of its affiliates or any other lender in their capacity as lenders to the Corporation or any of its Affiliates or Subsidiaries
pursuant to any agreement under which the Corporation or such Affiliate or Subsidiary has borrowed money. Without limiting the generality of the foregoing, neither Freeport nor any such Person, in exercising its rights as a lender, including making
its decision on whether to foreclose on any collateral security, will have any duty to consider (a) its status as a direct or indirect stockholder of the Corporation, (b) the interests of the Corporation or any of its Affiliates or
Subsidiaries or (c) any duty it may have to any other direct or indirect stockholder of the Corporation, except as may be required under the applicable loan documents. 
  

 35 

 IN WITNESS WHEREOF, the parties hereto have executed this Stockholders’ Agreement on the date
first written above. 
  

			
	ADDUS HOLDING CORPORATION
		
	By:	 	 /s/ Simon A. Bachleda

	Name:	 	Simon A. Bachleda
	Title:	 	Secretary

 Signature Page to 
 Holdings Stockholders’ Agreement 

			
	INVESTORS
	
	EOS CAPITAL PARTNERS III, LP
		
	By:	 	ECP General III, L.P., its General Partner
		
	By:	 	ECP III, LLC, its General Partner
		
	By:	 	 /s/ Brian D. Young

	Name:	 	Brian D. Young
	Title:	 	Chairman
	
	EOS PARTNERS SBIC III, L.P.
		
	By:	 	Eos SBIC General III, L.L.C., its General Partner
		
	By:	 	Eos Partners, L.P., its Managing Member
		
	By:	 	Eos General, L.L.C., its General Partner
		
	By:	 	 /s/ Brian D. Young

	Name:	 	Brian D. Young
	Title:	 	Managing Member
	
	FREEPORT LOAN FUND LLC
		
	By:	 	 /s/ Chad Blakeman

	Name:	 	Chad Blakeman
	Title:	 	Duly Authorized Signatory

 Signature Page to 
 Holdings Stockholders’ Agreement 

			
	MANAGEMENT STOCKHOLDERS
	
	 /s/ W. Andrew Wright, III

	W. Andrew Wright, III
	
	 /s/ Mark S. Heaney

	Mark S. Heaney
	
	 /s/ James A. Wright

	James A. Wright
	
	 /s/ Courtney E. Panzer

	Courtney E. Panzer
	
	ADDUS TERM TRUST
		
	By:	 	 /s/ W. Andrew Wright III

	Name:	 	W. Andrew Wright III
	Title:	 	Trustee
	
	W. ANDREW WRIGHT GRANTOR RETAINED ANNUITY TRUST
		
	By:	 	 /s/ W. Andrew Wright III

	Name:	 	W. Andrew Wright III
	Title:	 	Trustee

 Signature Page to 
 Holdings Stockholders’ Agreement 

 ANNEX I 
 INVESTORS 
  

			
	 Investor
	  	 Investor Shares

	 Eos Capital Partners III, L.P.
 c/o Eos Partners,
L.P.
 320 Park Avenue
 New York, New York 10022
 Telephone: (212) 832-5800
 Facsimile: (212) 832-5815
 Attn: Mark L. First
	  	28,940 shares of Series A Preferred Stock
		
	 Eos Partners SBIC III, L.P.
 320 Park
Avenue
 New York, New York 10022
 Telephone: (212) 832-5800

 Facsimile: (212) 832-5815
 Attn: Mark L.
First
	  	8,310 shares of Series A Preferred Stock
		
	In each case, with a copy (which shall not constitute notice) to:	  	
		
	 King & Spalding, LLP
 1185 Avenue of the
Americas
 New York, New York 10036
 Attention: Dominick P.
DeChiara, Esq.
 Telephone: (212) 827-4098
 Facsimile:
(212) 556-2222
	  	
		
	 Freeport Loan Fund LLC
 c/o Freeport Financial LLC

 500 West Madison Street, Suite 1710
 Chicago, Illinois 60661

 ATTN: Addus HealthCare, Inc. Account Officer
 Tel:
(312) 281-4605
 Fax: (312) 558-5700
	  	500 shares of Series A Preferred Stock
		
	In each case, with a copy (which shall not constitute notice) to:	  	
		
	 Winston & Strawn LLP
 35 West Wacker
Drive
 Chicago, Illinois 60601
 ATTN: Patrick
Hardiman
	  	
	 Tel: (312) 558-5634
 Fax:
(312) 558-5700
	  	

 ANNEX II 
 MANAGEMENT STOCKHOLDER 
  

			
	 Management Stockholder
	  	 Management Stockholder Shares

	 W. Andrew Wright, III
 281 Steeplechase Road

Barrington, IL 60010
	  	71,536 shares of Common Stock
		
	 Addus Term Trust
 281 Steeplechase Road
 Barrington, IL 60010
	  	3,114 shares of Common Stock
		
	 W. Andrew Wright Grantor Retained Annuity Trust
 281
Steeplechase Road
 Barrington, IL 60010
	  	12,552 shares of Common Stock
		
	 Mark S. Heaney
 1340 Inverness Lane
 Schereville, IN 46375
	  	5,285 shares of Common Stock
		
	 James A. Wright
 79 Spring Creek Road
 Barrington Hills, IL 60010
	  	944 shares of Common Stock
		
	 Courtney E. Panzer
 4N 539 Hidden Oaks Road
 St. Charles, IL 60175
	  	944 shares of Common Stock
		
	In each case, with a copy (which shall not constitute notice) to:	  	
		
	 Foley & Lardner LLP
 777 E Wisconsin
Avenue
 Milwaukee, WI 53202-5306
 Attention: Patrick G. Quick,
Esq.
 Telephone: (414) 271-2400
 Facsimile:
(414) 297-4900
	  	

 ANNEX III 
  

					
	  	  	 Alternate Directors
	  	 
		  	James A. Wright	  	
		  	Elaine M. Wright	  	
		  	Jeffrey R. Lange	  	
		  	Susan Heaney	  	
		  	Christopher Heaney	  	
		  	Robert Mrofka	  	

  

 2 

 EXHIBIT A 
 STOCKHOLDERS’ AGREEMENT JOINDER 
 By execution of this Joinder, the
undersigned agrees to become a party to that certain Stockholders’ Agreement dated as of September 19, 2006, among Addus Holdings Corporation and the Stockholders which are parties thereto (as the same may be amended, restated or otherwise
modified from time-to-time). The undersigned shall have all the rights, and shall observe all the obligations, applicable to a Stockholder and [Investor] [Management Stockholder] thereunder. 
  

							
	Name:	 	  
	 		 	

  

					
	Address for	 	with copies	 	
	Notices:	 	to:Registration Rights Agreement

 Exhibit 4.3 
  
  
  
 ADDUS HOLDING CORPORATION 
 REGISTRATION RIGHTS AGREEMENT 
 September 19, 2006 
  
  
  

 Table of Contents 
  

					
	Section 1.	  	Definitions	  	1
	Section 2.	  	Required Registration	  	4
	Section 3.	  	Piggyback Registration	  	5
	Section 4.	  	Registrations on Form S-3	  	5
	Section 5.	  	Holdback Agreement	  	6
	Section 6.	  	Preparation and Filing	  	7
	Section 7.	  	Expenses	  	9
	Section 8.	  	Indemnification	  	9
	Section 9.	  	Information by Holder	  	12
	Section 10.	  	Exchange Act Compliance	  	12
	Section 11.	  	No Conflict of Rights; Future Rights	  	12
	Section 12.	  	Termination	  	12
	Section 13.	  	Benefits of Agreement; Third Party Beneficiaries	  	12
	Section 14.	  	Assignment	  	12
	Section 15.	  	Entire Agreement	  	13
	Section 16.	  	Notices	  	13
	Section 17.	  	Modifications; Amendments; Waivers	  	14
	Section 18.	  	Counterparts; Electronic Signatures	  	14
	Section 19.	  	Headings	  	14
	Section 20.	  	Governing Law; Consent to Jurisdiction and Venue; Waiver of Jury Trial	  	15
	Section 21.	  	Severability	  	16

  

 i 

 Execution Copy 
 REGISTRATION RIGHTS AGREEMENT, dated as of September 19, 2006 (this “Agreement”) among Addus Holding Corporation, a Delaware corporation (the “Corporation”), the Persons
listed on Annex I hereto and the Persons listed on Annex II hereto (collectively, the “Stockholders”). 
 WHEREAS, the Stockholders own or have the right to purchase or otherwise acquire shares of the Common Stock (as defined herein) of the Corporation, and 
 WHEREAS, the Corporation and the Stockholders deem it to be in their respective best interests to set forth their rights in connection with public offerings and sales of the Common Stock and are entering into
this Agreement as a condition to and in connection with the Investors entering into the Securities Purchase Agreement (as defined herein) and the Management Stockholders (as defined herein) entering into that certain Stock Purchase Agreement (as
defined herein). 
 NOW, THEREFORE, in consideration of the promises and mutual covenants and obligations hereinafter set forth, the
Corporation and the Stockholders hereby agree as follows: 
 Section 1. Definitions. 
 As used in this Agreement, the following terms shall have the following meanings: 
 “Affiliate” has the meaning ascribed to such term in the Stockholders’ Agreement. 
 “Board” means the Board of Directors of the Corporation. 
 “Business Day” means any day that is not a Saturday, Sunday or a day on which banking institutions in New York, New York are not required to be open. 
 “Commission” means the Securities and Exchange Commission or any other agency at the time administering the Securities Act. 

“Common Stock” means the common stock, $0.001 par value per share, of the Corporation. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations of the
Commission promulgated thereunder, all as the same shall be in effect from time to time. 
 “Freeport” means Freeport Loan
Fund LLC and any Permitted Transferee thereof. 
 “Governmental Entity” has the meaning ascribed to such term in the Stock
Purchase Agreement. 

 “Group” has the meaning ascribed to such term in the Stockholders’ Agreement.

 “IPO” shall mean the Corporation’s initial public offering of shares of its Common Stock pursuant to a registration
statement declared effective under the Securities Act. 
 “Investors” means the holders of Restricted Shares identified on
Annex I hereto and includes any successor to, or assignee or transferee of, any such Person who or which agrees in writing to be treated as an Investor hereunder and to be bound by the terms and comply with all applicable provisions hereof.

 “Investor Shares” means all Registrable Shares held at any time during the term of this Agreement by the Investors.

 “Majority in Interest” means, (i) with respect to the Investor Shares, the holders of at least a majority of the
Investor Shares then outstanding and (ii) with respect to the Management Stockholder Shares, the holders of at least a majority of the Management Stockholder Shares then outstanding, and, if applicable, the Original Management Stockholder
Threshold. 
 “Management Stockholders” means the holders of Restricted Shares identified on Annex II hereto and
includes any successor to, or assignee or transferee of, any such Person who or which agrees in writing to be treated as a Management Stockholder hereunder and to be bound by the terms and comply with all applicable provisions hereof. 
 “Management Stockholder Shares” means all Registrable Shares held at any time during the term of this Agreement by the Management
Stockholders. 
 “Original Management Stockholder Shares” means the Management Stockholder Shares outstanding on the date
hereof. 
 “Original Management Stockholder Threshold” means the holders of a majority of the Original Management
Stockholder Shares so long as at least fifty percent (50%) of the Original Management Stockholder Shares remain outstanding. 
 “Other Shares” means at any time those shares of Common Stock which do not constitute Primary Shares or Registrable Shares hereunder. 
 “Person” has the meaning ascribed to it in the Stockholders’ Agreement. 
 “Primary Shares” means at any time authorized but unissued shares of Common Stock. 
 “Public
Sale” means any sale, occurring simultaneously with or after an offering of securities to the public pursuant to an offering registered under the Securities Act or to the public through a broker, dealer or market maker (pursuant to the
provisions of Rule 144 or otherwise). 
  

 -2- 

 “Registrable Shares” means the shares of Common Stock held by the Stockholders which
constitute Restricted Shares. For purposes of this definition, a Stockholder shall be deemed to be the holder of shares of Common Stock whenever such Stockholder has the right to acquire, directly or indirectly, shares of Common Stock upon the
conversion or exercise of Restricted Shares (but disregarding any restrictions or limitations upon the exercise of such right), whether or not such acquisition has actually been effected. 
 “Restricted Shares” means shares of Common Stock held by any Stockholder and any other securities which by their terms are exercisable
or exchangeable for or convertible into Common Stock which are held by such Stockholder (including exercised or unexercised warrants for preferred stock or Common Stock or convertible debt securities). As to any particular Restricted Shares, once
issued, such Restricted Shares shall cease to be Restricted Shares when (i) they have been registered under the Securities Act, the registration statement in connection therewith has been declared effective and they have been disposed of
pursuant to such effective registration statement, (ii) they, together with all other Securities held by a Stockholder, are eligible to be sold or distributed pursuant to Rule 144 (including, without limitation, Rule 144(k)) in a single
transaction by such Stockholder without limitation, (iii) they shall have ceased to be outstanding or (iv) they have otherwise been transferred and new certificates or other evidences of ownership for them not bearing a restrictive legend
and not subject to any stop transfer order or other restriction on transfer shall have been delivered by the Corporation or the issuer of other securities issued in exchange for the Restricted Shares. 
 “Registration Date” means the date upon which the registration statement pursuant to an IPO shall have been declared effective.

 “Rule 144” means Rule 144 promulgated under the Securities Act or any successor rule thereto or any complementary rule
thereto (such as Rule 144A). 
 “Securities Act” means the Securities Act of 1933, as amended, or any successor statute, and
the rules and regulations of the Commission thereunder, all as the same shall be in effect from time to time. 
 “Securities Purchase
Agreement” means the Securities Purchase Agreement dated as of the date hereof, among the Corporation and the Investors, as the same may be modified, supplemented or amended from time to time. 
 “Stockholders” has the meaning ascribed to it in the Preamble. 
 “Stockholders’ Agreement” means the Stockholders’ Agreement dated as of the date hereof, among the Corporation and the
Stockholders, as the same may be amended, restated, modified, or otherwise supplemented from time-to-time. 
 “Stock Purchase
Agreement” means the Stock Purchase Agreement, dated as of September 19, 2006, by and among the Corporation, Addus Management Corporation, Addus Acquisition Corporation, Addus HealthCare, Inc., W. Andrew Wright, III, as Sellers’
Representative and the Sellers parties thereto, as it may be amended, restated, modified or otherwise supplemented from time-to-time. 
  

 -3- 

 “Transfers” has the meaning ascribed to it in the Stockholders’ Agreement.

 Section 2. Required Registration. 
 (a) At any time after the date that is six (6) months following the consummation of an IPO, if (i) a Majority in Interest of the Investors shall request that the Corporation effect the registration of
Registrable Shares under the Securities Act (an “Investor Demand”) or (ii) a Majority in Interest of the Management Stockholders shall request that the Corporation effect the registration of Registrable Shares under the
Securities Act (a “Management Stockholder Demand”), the Corporation shall promptly use its best efforts to effect the registration under the Securities Act of such Investors’ or Management Stockholders’, as applicable,
Registrable Shares. 
 (b) Notwithstanding anything contained in this Section 2 to the contrary, the Corporation shall not be obligated
to effect any registration under the Securities Act except in accordance with the following provisions: 
 (i) The Corporation
shall not be obligated to file and cause to become effective more than three (3) Investor Demands or more than one (1) Management Stockholder Demand on Form S-1 promulgated under the Securities Act (or any successor form thereto).

 (ii) The Corporation may delay the filing or effectiveness of any registration statement for a period of up to thirty
(30) days after the date of a request for registration pursuant to Section 2(a) if at the time of such request: (X) the Corporation is engaged, or has fixed plans to engage within fifteen (15) days of the time of such request, in
a firm commitment underwritten public offering of Primary Shares in which the holders of Registrable Shares have been or will be permitted to include all the Registrable Shares so requested to be registered pursuant to Section 3 or (Y) the
Board reasonably determines that such registration and offering would interfere with any material transaction involving the Corporation; provided, however, that the Corporation shall only be entitled to invoke its rights under this
Section 2(b)(ii) one time during any twelve month period. 
 (iii) With respect to any registration pursuant to this
Section 2 and Section 4, the Corporation shall give notice of such registration to the Stockholders who do not request registration hereunder at least thirty (30) days before the initial filing of the registration statement related
thereto and, upon the request delivered to the Corporation within twenty (20) days after delivery of any such notice by the Corporation, such non-requesting stockholders may include in such registration any Registrable Shares then held by such
non-requesting stockholders and the Corporation may include in such registration any Primary Shares or Other Shares; provided, however, that if the managing underwriter advises the Corporation that the inclusion of all Registrable
Shares, Primary Shares and/or Other Shares proposed to be included in such registration would interfere with the successful marketing (including pricing) of the Registrable Shares proposed to be included in such registration, then the number of
Registrable Shares, Primary Shares and/or Other Shares proposed to be included in such registration shall be included in the following order: 
 (A) first, the Registrable Shares (or, if necessary, such Registrable Shares pro rata among the holders thereof based upon the number of Registrable Shares requested to be registered by each such holder); 

 

 -4- 

 (B) second, the Primary Shares; and 
 (C) third, the Other Shares. 
 (iv) If the holders of the Registrable Shares requesting to be included in a registration pursuant to Section 2(a) so elect, the offering of such Registrable Shares pursuant to such registration shall be in the
form of an underwritten offering. The holders of Registrable Shares requesting such registration shall select one or more nationally recognized firms of investment bankers reasonably acceptable to the Corporation to act as the lead managing
underwriter or underwriters in connection with such offering. 
 (v) At any time before the registration statement covering
such Registrable Shares becomes effective, the holders of a majority of such shares may request the Corporation to withdraw or not to file the registration statement. In that event, the holders shall not be deemed to have used an Investor Demand or
a Management Stockholder Demand, as applicable, under Section 2(a). 
 Section 3. Piggyback Registration. 
 If the Corporation at any time proposes for any reason to register Primary Shares or Other Shares under the Securities Act (other than on Form S-4 or Form
S-8 promulgated under the Securities Act (or any successor forms thereto)), it shall give written notice to the Stockholders of its intention to so register such Primary Shares or Other Shares at least thirty (30) days before the initial filing
of the registration statement related thereto and, upon the request, delivered to the Corporation within twenty (20) days after delivery of any such notice by the Corporation, of the Stockholders to include in such registration Registrable
Shares (which request shall specify the number of Registrable Shares proposed to be included in such registration), the Corporation shall use its best efforts to cause all such Registrable Shares to be included in such registration on the same terms
and conditions as the securities otherwise being sold in such registration; provided, however, that if the managing underwriter advises the Corporation that the inclusion of all Registrable Shares requested to be included in such
registration would interfere with the successful marketing (including pricing) of the Primary Shares or Other Shares proposed to be registered by the Corporation, then the number of Primary Shares, Registrable Shares and Other Shares proposed to be
included in such registration shall be included in the order set forth in Section 2(b)(iii). 
 Section 4. Registrations on Form
S-3. 
 Anything contained in Section 2 to the contrary notwithstanding, at such time as the Corporation shall have qualified for the
use of Form S-3 promulgated under the Securities Act or any successor form thereto, a Majority in Interest of the Investors shall have the right to 

  

 -5- 

 
request an unlimited number of registrations of Registrable Shares and a Majority in Interest of the Management Stockholders shall have the right to request
three (3) registration of Registrable Shares on Form S-3 (which may, at such holders’ request, be shelf registrations pursuant to Rule 415 promulgated under the Securities Act) or its successor form, which request or requests shall
(i) specify the number of Registrable Shares intended to be sold or disposed of and the holders thereof, (ii) state whether the intended method of disposition of such Registrable Shares is an underwritten offering or a shelf registration
and (iii) relate to Registrable Shares having an aggregate offering price of at least $2,000,000. A requested registration on Form S-3 (or its successor form) in compliance with this Section 4 shall not count as a registration statement
initiated pursuant to Section 2(a) but shall otherwise be treated as a registration initiated pursuant to Section 2(b) (including Section 2(b)(iii)). 
 Section 5. Holdback Agreement. 
 In connection with the IPO, each Stockholder agrees that he, she
or it, shall not, directly or indirectly, sell publicly, offer to sell publicly, make any short sale of, or otherwise dispose publicly of, any Restricted Shares (other than sales or dispositions to members of his, her or its Group and other than
with respect to those shares of Common Stock included in such registration), for a period (the “Lockup Period”) designated by the Corporation in writing to the Stockholders, which period shall not last more than 180 days after the
Registration Date (or such longer period as advised in good faith by the managing underwriter); provided, however, that 
 (a)
such agreement shall be applicable only to the first such registration statement of the Corporation that covers Common Stock to be sold on its behalf to the public in an underwritten offering; 
 (b) all then current executive officers, directors and 1% stockholders of the Corporation enter into similar agreements; and 
 (c) any release from the lock-up restrictions set forth in such agreements, anytime during the Lockup Period shall be done pro rata among the holders of
Registrable Shares, so that each holder of Registrable Shares may sell, transfer or otherwise dispose of an equal percentage of his, her or its shares originally subject to lock-up restrictions. 
 Each Stockholder agrees that the Corporation may instruct its transfer agent to place stop transfer notations, as reasonably necessary, to enforce this
provision. If (i) during the last seventeen (17) days of the Lockup Period the Corporation issues an earnings release or material news or a material event relating to the Corporation occurs, or (ii) prior to the expiration of the
Lockup Period, the Corporation announces that it will release earnings results during the sixteen (16) day period beginning on the last day of the Lockup Period; the restrictions imposed by this Section 5 shall continue to apply until the
expiration of the eighteen (18) day period beginning on the issuance of the earnings release or the occurrence of the material news or material event. 
  

 -6- 

 Section 6. Preparation and Filing. 
 If and whenever the Corporation is under an obligation pursuant to the provisions of this Agreement to effect the registration of any Registrable Shares,
the Corporation shall, as expeditiously as practicable: 
 (a) use its best efforts to cause a registration statement that registers such
Registrable Shares to become and remain effective until all of such Registrable Shares have been disposed of; 
 (b) furnish, at least five
(5) Business Days before filing a registration statement that registers such Registrable Shares, a prospectus relating thereto or any amendments or supplements relating to such registration statement or prospectus, to one counsel selected by
the holders of a majority of the Registrable Shares requesting such registration (the “Stockholders’ Counsel”), copies of all such documents proposed to be filed (it being understood that such five-business-day period need not
apply to successive drafts of the same document proposed to be filed so long as such successive drafts are supplied to the Stockholders’ Counsel in advance of the proposed filing by a period of time that is customary and reasonable under the
circumstances); 
 (c) prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus
used in connection therewith as may be necessary to keep such registration statement effective until all of such Registrable Shares have been disposed of and to comply with the provisions of the Securities Act with respect to the sale or other
disposition of such Registrable Shares; 
 (d) notify in writing the Stockholders’ Counsel (i) of the receipt by the Corporation of
any notification with respect to any comments by the Commission with respect to such registration statement or prospectus or any amendment or supplement thereto or any request by the Commission for the amending or supplementing thereof or for
additional information with respect thereto, (ii) of the receipt by the Corporation of any notification with respect to the issuance by the Commission of any stop order suspending the effectiveness of such registration statement or prospectus
or any amendment or supplement thereto or the initiation or threatening of any proceeding for that purpose and (iii) of the receipt by the Corporation of any notification with respect to the suspension of the qualification of such Registrable
Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purposes; 
 (e) use its best efforts to
register or qualify such Registrable Shares under such other securities or blue sky laws of such jurisdictions as the holders of Registrable Shares reasonably request and do any and all other acts and things which may be reasonably necessary or
advisable to enable the Stockholders to consummate the disposition in such jurisdictions of the Registrable Shares owned by the Stockholders; provided, however, that the Corporation will not be required to qualify generally to do
business, subject itself to general taxation or consent to general service of process in any jurisdiction where it would not otherwise be required to do so but for this paragraph (e); 
 (f) furnish to the Stockholders such number of copies of a summary prospectus, if any, or other prospectus, including a preliminary prospectus, in
conformity with the requirements of the Securities Act, and such other documents as such Stockholders may reasonably request in order to facilitate the public sale or other disposition of such Registrable Shares; 
  

 -7- 

 (g) without limiting subsection (e) above, use its best efforts to cause such Registrable Shares to
be registered with or approved by such other governmental agencies or authorities as may be necessary by virtue of the business and operations of the Corporation to enable the Stockholders holding such Registrable Shares to consummate the
disposition of such Registrable Shares; 
 (h) notify the Stockholders holding such Registrable Shares on a timely basis at any time when a
prospectus relating to such Registrable Shares or any document related thereto includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading
in light of the circumstances then existing and, at the request of the Stockholders prepare and furnish to such Stockholders a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as
thereafter delivered to the offerees of such shares, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading
in light of the circumstances then existing; 
 (i) make available upon reasonable notice and during normal business hours, for inspection by
the Stockholders holding such Registrable Shares, any underwriter participating in any disposition pursuant to such registration statement and any attorney, accountant or other agent retained by the Stockholders or underwriter (collectively, the
“Inspectors”), all pertinent financial and other records, pertinent documents and properties of the Corporation (collectively, the “Records”), as shall be reasonably necessary to enable them to exercise their due
diligence responsibility, and cause the Corporation’s officers, directors and employees to supply all information (together with the Records, the “Information”) reasonably requested by any such Inspector in connection with such
registration statement. Any of the Information which the Corporation determines in good faith to be confidential, and of which determination the Inspectors are so notified, shall not be disclosed by the Inspectors unless (i) the disclosure of
such Information is necessary to avoid or correct a material misstatement or omission in the registration statement, (ii) the release of such Information is ordered pursuant to a subpoena or other order from a court or governmental agency or
authority of competent jurisdiction, (iii) such Information has been made generally available to the public through no breach of the nondisclosure obligations of the Inspectors or their Affiliates or (iv) such disclosure is required to be
made under applicable law; 
 (j) use its best efforts to obtain from its independent certified public accountants “cold comfort”
letters in customary form and at customary times and covering matters of the type customarily covered by cold comfort letters; 
 (k) use its
best efforts to obtain from its counsel an opinion or opinions in customary form; 
 (l) provide a transfer agent and registrar (which may be
the same entity and which may be the Corporation) for such Registrable Shares; 
  

 -8- 

 (m) promptly issue to any underwriter to which the Stockholders holding such Registrable Shares may sell
shares in such offering certificates evidencing such Registrable Shares; 
 (n) list such Registrable Shares on any national securities
exchange on which any shares of the Common Stock are listed or, if the Common Stock is not listed on a national securities exchange, use its best efforts to qualify such Registrable Shares for inclusion on the automated quotation system of the
National Association of Securities Dealers, Inc. (the “NASD”), or such other national securities exchange as the holders of a majority of the Registrable Shares shall reasonably request; 
 (o) otherwise use its best efforts to comply with all applicable rules and regulations of the Commission and make available to its Stockholders, as soon
as reasonably practicable, earnings statements covering a period of twelve (12) months beginning within three months after the effective date of the subject registration statement; and 
 (p) otherwise use its best efforts to take all other steps necessary to effect the registration of such Registrable Shares contemplated hereby.

 Each holder of the Registrable Shares, upon receipt of any notice from the Corporation of any event of the kind described in
Section 6(h) hereof, shall forthwith discontinue disposition of the Registrable Shares pursuant to the registration statement covering such Registrable Shares until such holder’s receipt of the copies of the supplemented or amended
prospectus contemplated by Section 6(h) hereof, and, if so directed by the Corporation, such holder shall deliver to the Corporation all copies, other than permanent file copies then in such holder’s possession, of the prospectus covering
such Registrable Shares at the time of receipt of such notice. 
 Section 7. Expenses. 
 All expenses incurred by the Corporation and the Stockholders in complying with their obligations pursuant to this Agreement and in connection with the
registration and disposition of Registrable Shares, including, without limitation, all registration and filing fees (including all expenses incident to filing with the NASD), fees and expenses of complying with securities and blue sky laws, printing
expenses, fees and expenses of the Corporation’s counsel and accountants and fees and expenses of the Stockholders’ Counsel shall be paid by the Corporation; provided, however, that all underwriting discounts, selling
commissions applicable to the Registrable Shares and Other Shares shall be borne by the holders selling such Registrable Shares and Other Shares, in proportion to the number of Registrable Shares and Other Shares sold by each such holder.

 Section 8. Indemnification. 
 (a) In connection with any registration of any Registrable Shares under the Securities Act pursuant to this Agreement, the Corporation shall indemnify and hold harmless the holders of Registrable Shares, each of such
holder’s officers, directors, employees, members, partners, and advisors and their respective Affiliates, each underwriter, broker or any other person acting on behalf of the holders of Registrable Shares and each other Person, if any, who

  

 -9- 

 
controls any of the foregoing Persons within the meaning of the Securities Act against any losses, claims, damages, liabilities, or actions joint or several
(or actions in respect thereof), to which any of the foregoing persons may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an
untrue statement or allegedly untrue statement of a material fact contained in the registration statement under which such Registrable Shares were registered under the Securities Act, any preliminary prospectus or final prospectus contained therein
or otherwise filed with the Commission, any amendment or supplement thereto or any document incident to registration or qualification of any Registrable Shares, or arise out of or are based upon the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not misleading or, with respect to any prospectus, necessary to make the statements therein in light of the circumstances under which they were made not
misleading, or any violation by the Corporation of the Securities Act or state securities or blue sky laws applicable to the Corporation or relating to action or inaction required of the Corporation in connection with such registration or
qualification under such state securities or blue sky laws; and shall reimburse such Persons for any legal or other expenses reasonably incurred by any of them in connection with investigating or defending any such loss, claim, damage, liability or
action; provided, however, that the Corporation shall not be liable in any such case to a holder of Registrable Shares if and only to the extent that any such loss, claim, damage, liability or action (including any legal or other
expenses incurred) arises out of or is based upon an untrue statement or allegedly untrue statement or omission or alleged omission made in said registration statement, preliminary prospectus, final prospectus, amendment, supplement or document
incident to registration or qualification of any Registrable Shares in reliance upon and in conformity with written information furnished to the Corporation by such holder of Registrable Shares specifically for use in the preparation thereof;
provided further, however, that the foregoing indemnity agreement is subject to the condition that, insofar as it relates to any untrue statement, allegedly untrue statement, omission or alleged omission made in any preliminary
prospectus but eliminated or remedied in the final prospectus, such indemnity agreement shall not inure to the benefit of any of such Persons if a copy of such final prospectus had been made available to such Persons and such final prospectus was
not delivered to the purchaser of the Registrable Shares with or prior to the written confirmation of the sale of such Registrable Shares. 
 (b) In connection with any registration of Registrable Shares under the Securities Act pursuant to this Agreement, each holder of Registrable Shares shall severally (based on the percentage of all Registrable, Primary and Other Shares
included in such registration that were owned by such holder) and not jointly and severally indemnify and hold harmless (in the same manner and to the same extent as set forth in Section 8(a)) the Corporation, each director of the Corporation,
each officer of the Corporation who shall sign such registration statement, each underwriter, broker or other person acting on behalf of the holders of Registrable Shares and each person who controls any of the foregoing persons within the meaning
of the Securities Act with respect to any statement or omission from such registration statement, any preliminary prospectus or final prospectus contained therein or otherwise filed with the Commission, any amendment or supplement thereto or any
document incident to registration or qualification of any Registrable Shares, if such statement or omission was made in reliance upon and in conformity with written information furnished to the Corporation or such underwriter by such holder of
Registrable Shares specifically for use in 

  

 -10- 

 
connection with the preparation of such registration statement, preliminary prospectus, final prospectus, amendment, supplement or document; provided,
however, that the maximum amount of liability in respect of such indemnification shall be limited, in the case of each holder of Registrable Shares, to an amount equal to the net proceeds actually received by such holder from the sale of
Registrable Shares effected pursuant to such registration. 
 (c) Promptly after receipt by an indemnified party of notice of the
commencement of any action involving a claim referred to in this Section 8, such indemnified party will, if a claim in respect thereof is made against an indemnifying party, give written notice to the latter of the commencement of such action.
The failure of any indemnified party to notify an indemnifying party of any such action shall not (unless such failure shall have a material adverse effect on the indemnifying party) relieve the indemnifying party from any liability in respect of
such action that it may have to such indemnified party hereunder. In case any such action is brought against an indemnified party, the indemnifying party will be entitled to participate in and to assume the defense thereof, jointly with any other
indemnifying party similarly notified to the extent that it may wish, with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party of its election so to assume the defense
thereof, the indemnifying party shall not be responsible for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof; provided, however, that if any indemnified party shall have
reasonably concluded that there may be one or more legal or equitable defenses available to such indemnified party which are additional to or conflict with those available to the indemnifying party, or that such claim or litigation involves or could
have an effect upon matters beyond the scope of the indemnity agreement provided hereunder, the indemnifying party shall not have the right to assume the defense of such action on behalf of such indemnified party (but shall have the right to
participate therein with counsel of its choice) and such indemnifying party shall reimburse such indemnified party and any Person controlling such indemnified party for that portion of the fees and expenses of any counsel retained by the indemnified
party which is reasonably related to the matters covered by the indemnity agreement provided hereunder. If the indemnifying party is not entitled to, or elects not to, assume the defense of a claim, it will not be obligated to pay the fees and
expenses of more than one counsel with respect to such claim. 
 (d) If the indemnification provided for hereunder is held by a court of
competent jurisdiction to be unavailable to an indemnified party with respect to any loss, claim, damage, liability or action referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute
to the amounts paid or payable by such indemnified party as a result of such loss, claim, damage, liability or action in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified
party on the other in connection with the statements or omissions which resulted in such loss, claim, damage, liability or action as well as any other relevant equitable considerations. The relative fault of the indemnifying party and of the
indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties agree that it would not be just and equitable if
contribution pursuant hereto were determined by pro rata allocation or by any other method or allocation which does not take account of the equitable considerations referred to herein. No person guilty or liable of fraudulent
misrepresentation shall be entitled to contribution from any person. 
  

 -11- 

 Section 9. Information by Holder. 
 The Stockholders shall furnish to the Corporation such written information regarding the Stockholders and the distribution proposed by any Stockholders as
the Corporation or the managing underwriter may reasonably request in writing and as shall be reasonably required in connection with any registration referred to in this Agreement. 
 Section 10. Exchange Act Compliance. 
 From the Registration Date or such earlier date as a registration statement filed by the Corporation pursuant to the Exchange Act relating to any class of the Corporation’s securities shall have become effective, the Corporation shall
comply with all of the reporting requirements of the Exchange Act applicable to it and shall comply with all other public information reporting requirements of the Commission which are conditions to the availability of Rule 144. The Corporation
shall cooperate with the Stockholders in supplying such information as may be necessary for the Stockholders to complete and file any information reporting forms presently or hereafter required by the Commission as a condition to the availability of
Rule 144. 
 Section 11. No Conflict of Rights; Future Rights. 
 The Corporation shall not, after the date hereof, grant any registration rights which are superior to the rights granted to the Stockholders hereby. If at
any time following the date hereof, the Corporation shall grant to any present or future stockholder of the Corporation rights to in any manner cause or participate in any registration statement of the Corporation that, in the judgment of the
Stockholders holding a majority of the Registrable Shares, are superior to the rights granted to the Stockholders hereby, such grant shall be null, void and ultra vires. 
 Section 12. Termination. 
 This
Agreement shall terminate (except for Sections 7 and 8) and be of no further force or effect when there shall no longer be any Registrable Shares outstanding. 
 Section 13. Benefits of Agreement; Third Party Beneficiaries. 
 Except as provided herein, this
Agreement shall bind and inure to the benefit of the Corporation, the Stockholders and subject to Section 14, the respective successors and assigns of the Corporation and the Stockholders. The managing underwriter(s) of the IPO are intended
third party beneficiaries of the agreements of the Stockholders contained in Section 5. 
 Section 14. Assignment.

 The provisions regarding assignment contained in this Section 14 shall apply to all Restricted Shares now owned or hereafter acquired
by a Stockholder, including Restricted Shares acquired by reason of original issuance, dividend, distribution, exchange, conversion and acquisition of outstanding Restricted Shares from another Person, and such provisions shall 

  

 -12- 

 
apply to any Restricted Shares obtained by a Stockholder upon the exercise, exchange or conversion of any option, warrant or other derivative security. Each
Stockholder may assign its rights hereunder to any purchaser or transferee of Registrable Shares; provided, however, no Stockholder shall assign any of its rights hereunder to a Person not already a party to this Agreement as a
Stockholder unless and until such Person executes and delivers to the Corporation a Joinder Agreement, substantially in the form attached hereto as Exhibit A, pursuant to which such Person will thereupon become a party to, and be bound by and
obligated to comply with the terms and provisions of, this Agreement, as a Stockholder hereunder and further, (x) if such Person is an employee, officer or director of the Corporation or any of its Subsidiaries (but excluding any such director
who is also a director, officer, member, manager or partner of an Investor), as a “Management Stockholder” hereunder, and (y) otherwise, as an “Investor” hereunder. The Corporation may not assign any rights
hereunder without the consent of a majority in interest of the holders of a majority of the Registrable Shares then outstanding. 
 Section 15. Entire Agreement. 
 This Agreement, and the other writings referred to herein or delivered pursuant hereto,
contain the entire agreement among the parties hereto with respect to the subject matter hereof and supersede all prior and contemporaneous arrangements or understandings with respect thereto. 
 Section 16. Notices. 
 All
notices, requests, consents and other communications hereunder to any party shall be deemed to be sufficient if contained in a written instrument delivered in person or sent by telecopy, nationally-recognized overnight courier or first class
registered or certified mail, return receipt requested, postage prepaid, addressed to such party at the address set forth below or such other address as may hereafter be designated in writing by such party to the other parties: 
 (i) if to the Corporation: 
 Addus Holding Corporation 
 c/o Eos Management, Inc. 
 320 Park Avenue 
 New York, New York 10022 
 Attention: Mark L. First 
 Telephone:
(212) 832-5800 
 Facsimile: (212) 832-5815 
 with a copy (which shall not constitute notice) to: 
 King & Spalding, LLP 
 1185 Avenue of the Americas 
 New York, New
York 10036 
 Attention: Dominick P. DeChiara, Esq. 
 Telephone: (212) 827-4098 
 Facsimile: (212) 556-2222; 
  

 -13- 

 (ii) if to the Stockholders, to their respective addresses set forth on Annex I or
Annex II hereto. 
 All such notices, requests, consents and other communications shall be deemed to have been delivered (a) in
the case of personal delivery or delivery by telecopy, on the date of such delivery, (b) in the case of dispatch by nationally-recognized overnight courier, on the next Business Day following such dispatch and (c) in the case of mailing,
on the third Business Day after the posting thereof. 
 Section 17. Modifications; Amendments; Waivers. 
 The terms and provisions of this Agreement may not be modified or amended except pursuant to a writing signed by the Corporation and Stockholders holding
at least a majority of all Registrable Shares then outstanding; provided, however, any such modification or amendment that would have a disproportionate impact on the rights of (i) the Management Stockholders shall not be
effective without the prior written consent of a Majority in Interest of the Management Stockholders and (ii) Freeport shall not be effective without the prior written consent of Freeport. Any waiver of any provision of this Agreement requested
by any party hereto must be granted in advance, in writing by the party granting such waiver; provided, however, that a Majority in Interest of the Investors may grant a waiver on behalf of all Investors and a Majority in Interest of
the Management Stockholders may grant a waiver or effect a modification or amendment on behalf of all Management Stockholders. 
 Section 18. Counterparts; Electronic Signatures. 
 This Agreement may be executed in any number of original or
electronic counterparts, and each such counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement. 
 Section 19. Headings. 
 The
headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be a part of this Agreement. 
  

 -14- 

 Section 20. Governing Law; Dispute Resolution. 
 (a) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to
any law or rule that would cause the laws of any jurisdiction other than the State of Delaware to be applied. 
 (b) Dispute
Resolution. 
 (i) Any controversy or claim arising out of or relating to this Agreement (including, without limitation, as to
arbitrability), or the breach thereof, shall be settled by individual arbitration (as opposed to class or collective arbitration) administered by a Person (the “Arbitrator”) mutually selected by the parties to any such dispute. If
the parties are unable to agree upon the Arbitrator, they shall each select an arbitrator and the selected arbitrators shall appoint a separate arbitrator to act as the Arbitrator. For purposes of this Section 20(b), (x) if the dispute
involves the Investors as a group, a Majority in Interest of the Investors shall act on behalf of the Investors as a group, (y) if the dispute involves the Management Stockholders as a group, a Majority in Interest of the Management
Stockholders shall act on behalf of the Management Stockholders as a group, and (z) if the dispute involves the Company, the board of directors of the Company or a duly authorized officer shall act on behalf of the Company. 
 (ii) In the event of any dispute, claim, question or disagreement arising from or relating to this Agreement, or the breach hereof or thereof, the
parties shall use their commercially reasonable efforts to resolve the dispute, claim, question or disagreement. To this effect, each party to the dispute shall appoint a representative (a “Representative”) and the appointed
Representatives will meet in person or by telephone within ten (10) Business Days of any party’s receipt of a written notice informing that party of the existence of a dispute, claim, question or disagreement. If the Representatives do not
resolve or settle the matter within ten (10) Business Days after the initial meeting, or following any longer period as the parties may agree to in writing, the Representatives shall then immediately submit the dispute to binding arbitration in
accordance with this Section 20(b). 
 (iii) The arbitration hearing shall commence within ninety (90) calendar days after the
Arbitrator is selected, unless the Representatives agree to extend this time period. The arbitration shall take place in New York, New York. 
 (iv) The arbitration shall be conducted pursuant to the Federal Rules of Procedure and the Federal Rules of Evidence. The Arbitrator will have full power to give directions and make such orders as the Arbitrator deems just. Nonetheless, the
Arbitrator explicitly shall not have the authority, power, or right to alter, change, amend, modify, add, or subtract from any provision of this Agreement. 
 (v) The Arbitrator shall issue a written decision within thirty (30) days after the conclusion of the arbitration hearing, which decision shall be rendered without reference to the reason for the
arbitrator’s decision or any citation to precedent. The agreement to arbitrate will be specifically enforceable. The award rendered by the 

  

 -15- 

 
arbitrator shall be final and binding (absent fraud or manifest error), and any arbitration award may be enforced by judgment entered in any court of
competent jurisdiction. The fees and expenses of the arbitrator shall be allocated between the parties to the dispute in the same proportion that the aggregate amount of the disputed items submitted to the Arbitrator that is unsuccessfully disputed
by each such party (as finally determined by the Arbitrator) bears to the total amount of such disputed items so submitted. 
 (vi) During
any arbitration proceeding, the parties shall continue to perform their respective obligations under this Agreement. 
 Section 21.
Severability. 
 It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent
permissible under the law and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, in the event that any provision of this Agreement would be held in any jurisdiction to be invalid, prohibited or unenforceable
for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding
the foregoing, if such provision could be more narrowly drawn so as not be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this
Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. 
 *  *  *  *

  

 -16- 

 IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement on the
date first written above. 
  

			
	ADDUS HOLDING CORPORATION
		
	By:	 	 /s/ Simon A. Bachleda

	Name:	 	Simon A. Bachleda
	Title:	 	Secretary

 Registration Rights Agreement 

			
	INVESTORS
	
	EOS CAPITAL PARTNERS III, L.P.
	
	By: ECP General III, L.P., its General Partner
	
	By: ECP III, LLC, its General Partner
		
	By:	 	 /s/ Brian D. Young

	Name:	 	Brian D. Young
	Title:	 	Managing Member
	
	EOS PARTNERS SBIC III, L.P.
	
	By: Eos SBIC General III, L.L.C, its General Partner
	
	By: Eos Partners, L.P., its Managing Member
	
	By: Eos General, L.L.C, its General Partner
		
	By:	 	 /s/ Brian D. Young

	Name:	 	Brian D. Young
	Title:	 	Managing Member
	
	FREEPORT LOAN FUND LLC
		
	By:	 	 /s/ Chad Blakeman

	Name:	 	Chad Blakeman
	Title:	 	Duly Authorized Signatory

  

 Registration Rights Agreement 

			
	MANAGEMENT STOCKHOLDERS
	
	 /s/ W. Andrew Wright, III

	W. Andrew Wright, III
	
	 /s/ Mark S. Heaney

	Mark S. Heaney
	
	 /s/ James A. Wright

	James A. Wright
	
	 /s/ Courtney E. Panzer

	Courtney E. Panzer
	
	ADDUS TERM TRUST
		
	By:	 	 /s/ W. Andrew Wright, III

	Name:	 	W. Andrew Wright III
	Title:	 	Trustee
	
	W. ANDREW WRIGHT GRANTOR RETAINED ANNUITY TRUST
		
	By:	 	 /s/ W. Andrew Wright, III

	Name:	 	W. Andrew Wright III
	Title:	 	Trustee

  

 Registration Rights Agreement 

 EXHIBIT A 
 REGISTRATION RIGHTS JOINDER 
 By execution of this Joinder, the undersigned agrees to become a party
to that certain Registration Rights Agreement dated as of September 19, 2006 among Addus Holding Corporation, a Delaware corporation, and the Stockholders which are parties thereto (as the same may be amended, restated or otherwise modified
from time to time). The undersigned shall have all the rights, and shall observe all the obligations, applicable to a Stockholder and [Investor] [Management Stockholder] thereunder. 
  

			
	Name:	 	  

  

					
	Address for Notices:	 		 	with copies to:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]